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ABSTRACT
Sleep and Cardiovascular Reactivity to an Acute Virtual Stressor
Alaina Tiani, M.S.
Inappropriate response and magnitude of cardiovascular reactivity (CVR) to stress is a proposed
mechanism through which environmental stressors are linked with poor cardiovascular health
outcomes (Chida & Steptoe, 2010; Krantz & Manuck, 1984). Studies of reactivity to various
laboratory tasks commonly control for factors known to influence CVR such as smoking,
medication use, caffeine intake, and BMI; however, few have considered the influence of sleep
on CVR. In order to determine whether sleep characteristics need to be assessed and considered
in studies of CVR, this study aimed to examine the association between indices of sleep quality
and the magnitude and patterning of CVR to an acute virtual stress task protocol. Fifty
undergraduate participants were recruited to complete three nights of sleep measurement via
actigraphy, followed by a virtual stress task during the daytime after the third night. The stress
protocol involved both a mental arithmetic and Raven’s matrices task that were completed under
time and accuracy pressure. Tasks were completed in counterbalanced order across participants
to control for order effects, and CVR measures included heart rate (HR) and heart rate variability
(HRV). It was hypothesized that decreases in total sleep time (TST) as well as decreases in sleep
efficiency (SE; e.g., increased sleep disruption) would be significantly associated with increases
in CVR to both stress tasks. Results did not reveal a significant association between CVR and
three-day average as well as prior night measures of TST and SE. However, a significant
association was observed between three-day wake after sleep onset (WASO) and measures of
HR and HRV reactivity. Increased frequency of WASO was associated with both increased heart
rate reactivity and decreased heart rate variability reactivity (less vagal reaction) to mental stress.
Although no associations were observed between affective responses to the two tasks and any
sleep parameter, decreased SE was associated with increased ratings of stressfulness to the
Raven's task and decreased TST was associated with lower ratings of perseverance to the
Raven's task. At least one parameter of sleep quality (i.e., WASO) was associated with
cardiovascular reactions to mental stress in the current study and may influence risk for
cardiovascular health as measured by CVR. Congruent with other studies examining the relation
between sleep parameters and CVR, findings from the current study suggest that quality of sleep
may be important to evaluate in future studies of CVR.
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Sleep and Cardiovascular Reactivity to an Acute Virtual Stressor
According to a 2020 report by the American Heart Association, cardiovascular diseases
remain the number one cause of death for adults in the United States and across the globe. In
2017 alone, cardiovascular disease (CVD) accounted for approximately 17.8 million deaths
worldwide, and this number is expected to reach over 22.2 million by the year 2030 (Virani et
al., 2020). Research has exposed a number of traditional risk factors for CVD morbidity and
mortality including health behaviors such as smoking, physical inactivity, poor nutrition, and
other comorbid conditions including obesity, diabetes, poor cholesterol levels, and high blood
pressure.
Despite decades of research regarding these risk factors, these health behaviors and
comorbid conditions alone do not explain all of the variance in predicting cardiovascular health
outcomes. For this reason, some investigators have turned to the examination of psychosocial
factors that influence physical health. One such factor speculated to contribute to cardiovascular
health outcomes was depression. Indeed, studies have shown that there is a robust bidirectional
association between depression and CVD, such that those with depression are at an increased
risk of eventually developing CVD, and that those who already have CVD are more likely to
experience depressive symptoms (Hare et al., 2014; Musselman et al., 1998). Other psychosocial
factors such as Type A personality traits (e.g., hostility, competitiveness, and aggression,
impatience), have also been linked with CVD outcomes, though less consistently than depression
(Espnes & Byrne, 2016; Friedman & Rosenman, 1960; Suls & Bunde, 2005). Research findings
in support of this association have found that those who demonstrated Type A personality traits
were more likely to develop CVD and have worse outcomes following a coronary event as
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compared to their Type B (e.g., relaxed, patient, easygoing) counterparts (Eysenck, 1991;
Rosenman et al., 1975).
In discovering these possible links between psychosocial factors and cardiovascular
health, investigators speculated about the mechanism through which psychological symptoms
and stress might “get under the skin.” One proposed mechanism was via physiological
influences, specifically cardiovascular reactivity (CVR) to stress. CVR refers to the magnitude of
change in cardiovascular parameters in response to a stressor. Common measures of CVR
include changes in blood pressure (BP) and heart rate (HR) between a rest period and the
presentation of a stressor, and each of these parameters are dually influenced by both the
sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) branches of the autonomic
nervous system. While changes in physiology are adaptive in order to meet the demands of a
stressor, inappropriate reactivity (including both exaggerated and blunted reactions), can pose a
risk to one’s heart health. Indeed, inappropriate CVR to stressors has been linked with poor
cardiovascular health outcomes, including essential hypertension, carotid atherosclerosis,
increased left ventricular mass, and coronary heart disease (Chida & Steptoe, 2010; Krantz &
Manuck, 1984; Treiber et al., 2003). As such, measuring one’s CVR to stress may help to
quantify the influence of this potential risk factor in terms of one’s future cardiovascular health
outcomes.
Measures of Cardiovascular Reactivity
Among the cardiovascular measures commonly used in studies involving CVR to
laboratory stress are measures of BP (systolic (SBP), diastolic (DBP), and mean arterial pressure
(MAP)). In addition, HR and related measures include heart rate variability (HRV) (high
frequency (HF) and low frequency (LF)). Additional measures of HRV include the ratio of LF to
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HF power (LF/HF ratio), respiratory sinus arrythmia (RSA), as well as the root mean square of
successive R-R interval differences (RMSSD). Each time the heart beats, a QRS wave complex
is generated on an electrocardiogram. An R-R interval represents the amount of time (in
milliseconds) elapsed between two successive R-waves (i.e., amount of time elapsed between
two successive heart beats). RMSSD then is a measure of heart rate variability across successive
beats and is not the same as heart rate, which is simply the average number of heart beats per
minute. Measures derived from impedance cardiography include pre-ejection period (PEP), leftventricular ejection time (LVET), cardiac output (CO), stroke volume (SV), and total peripheral
resistance (TPR). Various CVR parameters reveal differences in autonomic nervous system
activity, and each parameter is considered a measure of CVR because it represents a
cardiovascular and physiological change in response to a stressor. For example, HR is dually
innervated by the sympathetic and parasympathetic (or vagal) branches of the autonomic nervous
system. The sympathetic and parasympathetic nervous systems can best be described as similar
to the brakes and accelerator of a vehicle, in which the sympathetic system acts as the accelerator
(e.g., increasing HR and BP) and the parasympathetic system acts as the brakes (decreasing HR
and BP). Both systems are always “active,” but it is the relative balance between the two systems
that determines the magnitude of HR and BP at any given moment. BP is also innervated by both
branches of the autonomic nervous system; thus it is not possible to determine whether increases
in BP or HR are due to increased sympathetic nervous system drive, decreased parasympathetic
nervous system drive, or a summation of the two. Measures of HRV represent the variation in the
time interval (in milliseconds) between successive heartbeats, and more variability is considered
characteristic of a healthier heart (Goldberger, 1991). Measures of HRV can be classified as
frequency-domain, which estimate the distribution of power into frequency bands, including LF
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(0.04 – 0.15 Hz) and HF (0.15 – 0.4 Hz) HRV (Shaffer & Ginsberg, 2017). HF-HRV represents
parasympathetic/vagal influences on cardiovascular activity (Berntson et al., 1997; Yasuma &
Hayano, 2004). LF-HRV was once thought to reflect sympathetic nervous system activity
(Axelrod et al., 1987); however others argue that it more likely represents parasympathetic
nervous system input during rest. Thus, it is still unclear what LF-HRV represents in terms of
acute stress reactivity, though some have argued that the LF component of the HRV power
spectrum may be determined by parasympathetic activity (Reyes del Paso et al., 2013; Umetani
et al., 1998). The LF/HF ratio has been previously used to represent the balance between
sympathetic and parasympathetic influences; however this has also been contested in the
literature (Reyes del Paso et al., 2013). Time-domain measurements of HRV quantify the amount
of HRV in a given time period, and includes measures like RMSSD, which is considered an
index of vagal influences on HRV (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). RSA is HRV
in synchrony with respiration, such that the time intervals between successive heart beats are
shorter during inspiration and longer during expiration (reflecting an interaction between the
respiratory and circulatory systems) and has been used as an index of cardiac vagal function.
Both PEP and LVET are systolic time interval measures, and PEP represents the time elapsed
between depolarization of the left ventricle and ventricular contraction, while LVET represents
the time period when blood is ejected from the aortic valve (Newlin & Levenson, 1979). PEP is
most directly influenced via the sympathetic nervous system. CO is the amount of blood output
by each ventricle in a given time period, and SV is the amount of blood pumped from each
ventricle per contraction, and generally increases with sympathetic nervous system activation.
Finally, TPR is the resistance to blood flow by the entire systemic vasculature.
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Cardiovascular Reactivity Versus Recovery
The primary purpose of the current study is to examine cardiovascular reactivity to an
acute virtual stressor; however, analyses examining the influence of sleep quality on
cardiovascular recovery were also conducted. Cardiovascular reactivity is defined as the
difference or magnitude of change (typically an increase) in measures of cardiovascular activity
(e.g., HR, BP) between a resting baseline period of time and an exposure to an environmental
stressor (e.g., a challenging cognitive task or a physical cold pressor task). Cardiovascular
recovery, on the other hand, refers to the change in cardiovascular activity (usually a decrease)
between a period of stress exposure and a subsequent rest period when the stressor is removed
(Gerin, 2013). Exaggerated cardiovascular reactivity or minimal or prolonged reductions in
cardiovascular activity after a stressor is no longer present are both considered risk factors for
overall cardiovascular health outcomes (Gerin, 2013).
Factors Affecting Cardiovascular Reactivity to Stress
Studies measuring cardiovascular reactivity (CVR) to stress must account and control for
a number of external factors that may artificially influence measures of cardiovascular
functioning like HR and BP. In designing studies involving measurement of CVR, researchers
must be careful to consider a number of factors known to influence the magnitude and patterning
of the physiological response. These factors include presence of disorders or diseases of the
heart, use of medications known to affect autonomic function (e.g., beta blockers), and health
behaviors like the use of nicotine, alcohol, or caffeine, and exercise, among others.
There exists a breadth of literature that examines the influence of each of these variables
on CVR to stress. For example, in regard to the influence of cardiovascular diseases, Krantz and
colleagues (1991) examined CVR to mental stress in a sample of patients with coronary artery
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disease classified as either severe, moderate, or non-ischemic. Results indicated that those
classified as having severe ischemia exhibited significantly greater SBP increases to stress as
compared to both the moderate ischemia and non-ischemic groups. Other studies in participants
with hypertension have demonstrated that hypertensive status (and in some cases having
biological parents with hypertension) is associated with elevated CVR to laboratory stress
(Manuck et al., 1990). In reference to the influence of medications on CVR, Mills and Dimsdale
(1991) completed a review of 59 studies that examined the effects of beta-blockers on CVR to
various psychosocial stressors. They found that across several types of beta-blockers (e.g.,
selective and non-selective), beta-blocker use was significantly related to a reduction in HR
reactivity to stress. BP reactivity to stress, however, was not significantly affected by betablocker use. In addition, medications like stimulants, which are typically prescribed to treat
attention-deficit hyperactivity disorder, are also known to influence autonomic nervous system
activity by increasing sympathetic activity (increased HR and BP) (Elia & Vetter, 2010).
Other studies have looked at the effects of various substances on stress reactivity,
including nicotine, alcohol, and caffeine use. For example, one study which looked at smoking
status (e.g., current, ex, or non-smokers) in stress reactivity found that current smokers exhibited
reduced BP reactivity and increased HR reactivity to acute stressors when compared to ex- and
non-smokers (Phillips et al., 2009). The consumption of other substances such as alcohol and
caffeine are known to modify autonomic nervous system functioning as well.
The short-term effects of alcohol or caffeine ingestion on any one occasion show that alcohol
tends to increase HR and sympathetic activity, but not BP (likely due to peripheral vasodilation
effects), and caffeine tends to increase both HR and BP activity (Johnson et al., 1986; Lane &
Williams Jr., 1985; van de Borne et al., 1997; Zahn & Rapoport, 1987).
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Despite knowledge regarding the influence of these factors on autonomic function, one
important and universal health behavior not typically accounted for in studies of CVR is sleep.
Over recent years, sleep has become a health behavior of particular interest, as inadequate sleep
and poor sleep quality have become growing issues of public health concern in the United States
(Colten & Altevogt, 2006). According to a 2014 report from the Centers for Disease Control and
Prevention, over one-third of US adults report consistently obtaining less than 7 hours of sleep
per night (Liu et al. 2016), and approximately 10% of the population complain of insomnia
symptoms (Ohayon, 2002). Unfortunately, issues with sleep extend far beyond feelings of
fatigue, as poor sleep has been linked with poor health outcomes including metabolic syndrome
and chronic diseases like Type 2 diabetes, obesity, and cardiovascular disease (Beccuti &
Pannain, 2011; Gottlieb et al., 2005; Hall et al., 2008; Wolk et al. 2005). Indeed, one study
reported that some of the greatest prevalence rates for low sleep duration are in the southeastern
United States and in the states that comprise Appalachia, a region known to have high rates of
these chronic health issues (Liu et al., 2016).
The relation between sleep and cardiovascular activity is bidirectional in nature, as sleep
parameters like sleep quality and duration affect cardiovascular indices, and cardiovascular
indices in turn affect the nature and structure of sleep (Trinder et al., 2012). Furthermore,
cardiovascular activity exhibits a diurnal rhythm, resulting from the dual influence of the body’s
sleep-wake cycle and circadian rhythms (Burgess et al., 1997). For example, BP is generally
lowest during nighttime sleep when it exhibits a “dipping” profile, increases before waking, and
continues to increase throughout the day, with a peak in the afternoon before dropping again in
the evening (Gupta et al., 2010). Additionally, under normal sleep/wake conditions, HR is
generally highest during the daytime/wakefulness and lowest during the night/sleep, and HRV
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tends to be lower during the day and fluctuates with the sleep stage cycle during nighttime sleep
(Ako et al., 2003; Bonnemeier et al., 2003).
In looking beyond the normal 24-hour fluctuations in cardiovascular activity, some
studies have examined the ways in which nighttime sleep (in particular, disruptions to healthy
sleep) might be related to daytime resting cardiovascular activity, many using ambulatory
measures of BP and HR. Many studies of 24-hour ambulatory cardiovascular monitoring have
found that sleep was significantly related to mean 24-hour and next-day cardiovascular activity,
and most studies have found that shorter nighttime total sleep time is related to increased resting
sympathetic nervous system activity the next day (Nagai et al., 2010). For example, Mezick et al.
(2012) found that in a sample of adolescents, actigraphy-assessed shorter sleep duration was
associated with increased 48-hour ambulatory BP and higher nighttime BP. Just as well, in a
post-hoc analysis of 24-hour ambulatory BP monitoring data, Shulman and colleagues (2018)
found that mean 24-hour BP was significantly higher in those with shorter sleep duration (less
than seven hours) as compared to longer sleep duration (greater than 7 hours). In regard to HR,
Tochikubo and colleagues (1996) found that mean HR and the LF/HF ratio were significantly
higher after a night of insufficient sleep versus a night of normal sleep. Zhong and colleagues
(2005) assessed cardiovascular function in healthy subjects over a period of 36 hours of sleep
deprivation and results indicated that LF-HRV was significantly higher at 12 and 24 hours,
LF/HF was significantly higher at 12 hours, and HF was reduced at 12 hours from baseline.
More recently, Grimaldi and colleagues (2016) assessed the influence of circadian misalignment
and sleep restriction on autonomic functioning by comparing participants assigned to eight nights
of sleep restriction (five hours/night) with either a fixed bedtime or a bedtime delayed by 8.5
hours (on four of the eight nights). Across groups, sleep restriction was significantly associated
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with an increase in daytime HR, and restriction with circadian misalignment led to increased
nocturnal HR and reduced vagal tone (decreased RMSSD and increased LF/HF ratio) as
compared to the circadian aligned group.
In a study that compared participants with mild, asymptomatic obstructive sleep apnea
(OSA) to matched controls, those with OSA exhibited lower daytime HRV indices, suggestive of
reduced vagal modulation in these participants as a result of their poorer sleep quality
(Balachandran et al., 2012). Similarly, Kageyama and colleagues (1998) found that in a sample
of male white-collar workers, those who self-reported poorer sleep quality exhibited increased
sympathetic dominance (e.g., lower HF-HRV and increased HR) during a standing rest protocol.
Additionally, in those with chronic insomnia, resting daytime HR has been found to be elevated
when compared to those without insomnia, which is consistent with the hyperarousal model of
insomnia as proposed by Perlis et al. (1997). In all, results of the aforementioned studies suggest
that sleep does indeed influence cardiovascular activity while at rest.
In considering the link between sleep, cardiovascular activity, and disease, one
mechanism by which sleep may be related to increased risk of cardiovascular disease in
particular is via cardiovascular reactivity (CVR) to stress. If sleep is indeed associated with
CVR, it would be prudent to screen and methodologically or statistically control for measures of
participant sleep characteristics in future studies. In the following section, a review of the
literature examining the relation between sleep and CVR is provided.
Review of the Literature
In describing the previous research that has examined the relation between sleep quality
and CVR, studies are grouped according to participant sleep health status and experimenter
manipulation, including (1) normal sleepers (habitual sleep) (n = 8), (2) normal sleepers
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(experimenter induced sleep restriction and deprivation) (n = 7), and (3) insomniacs versus good
sleepers (n = 9). A summary of the state of the associations between sleep parameters and CVR
are summarized for each group here. For a more in-depth look at the literature examining the
relation between sleep and cardiovascular reactivity, See Appendix A.
Normal Sleepers (Habitual Sleep)
In summary of the eight studies that examined habitual sleep parameters in normal
sleepers, two studies found no significant associations between measures of sleep and CVR
(Brindle et al., 2018; Brindle & Conklin, 2012). Of the remaining six studies, all four studies that
measured sleep efficiency found that decreased sleep efficiency was significantly associated with
patterns of CVR consistent with increased sympathetic and decreased parasympathetic activation
in response to stress (Covassin et al., 2013; Lustyk et al., 2012; Massar et al., 2017; Palesh et al.,
2008). One of these four studies also measured REM sleep stage duration and found that
decreased REM duration was significantly associated with increased sympathetic/decreased
parasympathetic reactivity to stress (Covassin et al., 2013). Of the seven studies that measured
total sleep time, only one study found a significant association with CVR, such that decreased
total sleep time was associated with decreased parasympathetic reactivity (Mezick et al., 2014).
Of the two studies that measured wake after sleep onset, one study found that decreased
frequency and length of night awakenings was associated with increased parasympathetic
activity in response to stress (Palesh et al., 2008). One study that utilized a global self-report
measure of sleep disturbance found that poorer sleep quality/more disturbances was associated
significantly with decreased DBP reactivity (Williams et al., 2013). No significant associations
were found between sleep onset latency, time in bed, or slow wave sleep duration and CVR
across all eight studies. In sum, it appears that increases in sleep disturbances as measured by
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sleep efficiency and wake after sleep onset are most consistently associated with increased
sympathetic influences and greater CVR to stress.
Normal Sleepers (Sleep Restriction and Deprivation)
Among the seven studies that examined the influence of sleep restriction and deprivation
on CVR to stress in a sample of otherwise normal sleepers, one study found no significant
association between total sleep deprivation versus normal sleep and CVR (Kato et al., 2000). Of
the remaining six studies, three found that increases in hours of sleep deprivation or restriction
were significantly associated with a patterning of CVR indicative of increased sympathetic
reactivity to stress (Franzen et al., 2011; Yang et al., 2012; Zhong et al., 2005). One study found
that increased deprivation was associated with decreased SBP reactivity to stress (O’Leary et al.,
2013). The remaining two studies contained somewhat contradictory results, as one found that
increased deprivation was associated with decreased HR and CO responses to stress but
increased TPR response to stress (James & Gregg, 2004), and another found that increased
deprivation was associated with an initial increase in SBP reactivity in the beginning of a
physical stress task, followed by a decrease in HR reactivity toward the end of the task (Muenter
et al., 2000). Due to the small number of studies that found support for a positive relation
between sleep deprivation and increased sympathetic activity in response to stress, it is thus
unclear how restriction of sleep influences CVR.
Insomniacs Versus Good Sleepers
In considering the results of the nine studies that examined differences in CVR between
groups of insomniacs and good sleepers, three studies found no significant difference in
measures of CVR between those with and without insomnia (Chen et al., 2017; Haynes et al.,
1981; Young, 2011). Chen and colleagues (2017) analyzed continuous sleep parameters across
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all participants (those with insomnia as well as good sleepers), and found that increased sleep
disruption (i.e., increased sleep onset latency, reduced total sleep time, and decreased sleep
efficiency) was significantly associated with increased sympathetic reactivity to stress. Of the
remaining six studies, five found a significant difference in the patterning of CVR between
insomniacs and good sleepers consistent with increased sympathetic activity in response to stress
(Carter et al., 2018; Cellini et al., 2014; Covassin et al., 2011; Schmidt et al., 2010; Stepanski et
al., 1994). The study by Castro-Diehl and colleagues (2016) found contradictory findings, such
that those with lower total sleep time and insomnia exhibited increased heart rate and increased
HF-HRV (i.e., increased parasympathetic response) to a stressor compared to those with higher
total sleep time and no insomnia. In addition, when they conducted analyses across participant
groups, decreased total sleep time was significantly associated with increased HR reactivity.
Taken together, it appears that the majority of the studies found support for increased
sympathetic reactivity to stress in those classified as having insomnia.
Aims of the Proposed Study
A review of the literature examining the relation between sleep and CVR to stressors has
revealed mixed and sometimes contradictory findings. However, it is commonly reported that
increased sleep disruption (predominantly when measured via sleep efficiency) and insomnia
status tend to be associated with increased sympathetic nervous system response to stressors as
compared to undisturbed sleep and normal sleep status. The purpose of the current study was
informed by the mixed findings in the literature and had two main aims.
Aim 1: In considering the overall variability in findings regarding the relation between
sleep and measures of cardiovascular reactivity to stress, the first aim of the current study was to
replicate previous research examining whether sleep was associated with CVR to mental stress.
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In contrast to previous work that relied on measurement of CVR in laboratory settings and
frequent use of polysomnography for measuring sleep parameters, little is known about whether
relations between CVR and sleep would be observed in more natural environments. Although the
current study was initially designed to measure CVR in a laboratory setting, the onset and
sustained presence of the COVID-19 pandemic provided the opportunity to develop and
implement the methodology to measure both sleep and CVR in participants’ normal living
environments (Tiani, in press).
Hypothesis 1: Based on prior research, it was hypothesized that decreases in total sleep
time as well as decreases in sleep efficiency (i.e., increased sleep disruption) would be
significantly associated with increased CVR to the stress tasks.
Hypothesis 2: Although less commonly observed in the previous literature, it was also
hypothesized that other measures of sleep disruption (e.g., increased wake after sleep onset;
increased number/duration of nighttime awakenings) would be significantly associated with
increased CVR to the stress tasks.
Aim 2: The second aim of the current study is to examine whether sleep characteristics
significantly predict cardiovascular recovery following the two cognitive stress tasks, as only
seven of the 24 reviewed studies have examined this relation. Of the seven studies that conducted
cardiovascular recovery analyses, one study did not detect significant differences in
physiological recovery between total sleep deprivation and normal sleep groups (Franzen et al.,
2011). Of the remaining six studies, four of the studies found that poorer sleep (as measured via
decreased total sleep time and decreased sleep efficiency) was associated with delayed or
prolonged recovery from stress (Brindle & Conklin, 2012; Massar et al., 2017; Mezick et al.,
2014; Yang et al., 2012). Two of the six studies found that poor sleep (as measured by decreased
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sleep duration and insomnia symptoms) was significantly associated with greater increases in
vagal tone during recovery as well as faster return to baseline HR levels (Castro-Diehl et al.,
2016; Young, 2011). Due to the mixed nature of these findings, further investigation of
cardiovascular recovery from stress is warranted.
Hypothesis 3: Decreases in total sleep time and sleep efficiency would be significantly
associated with prolonged HR recovery following the stressors.
In addition to these main study aims, the proposed study was designed to address some of
the methodological and statistical shortcomings of prior work. For example, numerous studies
comprising this literature failed to account for some of the confounding variables known to
influence both CVR and sleep, including methodological factors such as participant use of
medications, substance use, and physical activity, and statistical factors such as time of day and
chronotype analyses, and consideration of potentially important covariates. The current study
addressed these and other variables to ensure that any significant association between sleep and
CVR could be solely attributed to the measured sleep parameters.
Of note, due to limitations imposed by the COVID-19 pandemic and the need to conduct
a virtual stress protocol, only HR and associated measures of HRV were measured remotely.
Typical in-person studies in our laboratory also involve measures of BP; however, remote BP
measurement was not possible due to equipment availability.
To achieve these aims, the current study employed a multi-method assessment of sleep
among undergraduate students across three weekdays, including both self-reported and
actigraphy-determined measures of pertinent sleep parameters. On the final day of the study,
participants completed two mental tasks presented remotely to assess measures of CVR as well
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as measures of affective reactivity to tasks and task appraisals. College students were selected as
participants because they are relatively healthy and display a broad range of sleep patterns.
Method
Participants
Fifty undergraduate students (43 female; 6 male; 1 other) enrolled in introductory
psychology courses at West Virginia University were recruited for participation in the study.
Students were excluded from the initial pool of participants if they were younger than 18 years of
age, had any chronic major health concerns (e.g., heart disease, cancer, diabetes), had a
neurological disorder (e.g., epilepsy), were pregnant, were currently using tobacco products
regularly (e.g., daily or weekly, as opposed to sporadic or occasional use), were currently using
recreational or illicit substances regularly (e.g., cocaine, marijuana, heroin, methamphetamine,
etc.), or were taking medications or other substances that are known to influence heart rate (e.g.,
beta blockers, stimulants). In addition, participants were excluded if they had a somatic health
concern that might influence sleep (e.g., pain, GERD), if they had a sleep disorder other than
insomnia (e.g., obstructive sleep apnea or sleep-disordered breathing, narcolepsy, NREM
parasomnia, restless leg syndrome), if they had a non-nocturnal habitual sleep schedule, or if
they engaged in night shift work. Though not an exclusionary criterion, participants were asked
to identify any sleep aids or supplements they took regularly (e.g., melatonin, Zzzquil), and
frequency of use. Of note, 12 participants reported using melatonin, and frequency of use ranged
from five nights per week to one night per month, with a mean frequency of approximately six
nights per month. Fifty-five participants completed the full study protocol; however, five female
participants were excluded from analyses, resulting in a final sample of 50 participants. Reasons
for exclusion included two participants who did not have sleep data due to actigraph watch
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malfunction, one who failed to return study equipment, one participant who had a poor HR
signal and significant HR data noise, and one participant who was suspected of using a calculator
to complete the mental arithmetic task.
In addition, eligible participants were required to have access to a smart phone or tablet
with Bluetooth capabilities. Eligible participants were asked to abstain from caffeine, alcohol,
tobacco (if sporadic or occasional users), and vigorous exercise for 2 hours prior to the virtual
stress task experimental session. Participants were advised to consume caffeine, alcohol, or
tobacco and engage in physical activity and exercise as they typically would on the days
preceding the virtual stress task when they were wearing the actigraph.
Sample size for the current study was based on a power analysis using G*Power (Version
3.1), and using effect sizes from studies that measured similar variables (Covassin et al., 2013;
Lustyk et al., 2012; Massar et al., 2007; Mezick et al., 2014). Each of the four studies reported
different types of effect sizes; Covassin reported Pearson’s r correlations ranging from 0.5 to 0.7,
Lustyk reported a Beta coefficient of 0.41 at p < .01, Massar reported Beta coefficients of 0.28 at
p < .05 and 0.34 at p < .001, and Mezick reported a Beta coefficient of 0.29 at p < .05. In order to
conduct a series of multiple regression analyses, an F test with an alpha level of 0.05, power of
0.80, two predictor variables, one covariate, and a medium effect size of f2 = 0.25 (based on
effect sizes reported in the literature) was selected, and this yielded a recommended sample size
of 50 participants.
Physiological Measures
Heart Rate (HR)
HR was measured using a Model H10 Polar heart rate monitor (Bethpage, New York).
This device is a strap worn around the participant’s chest and measures HR in a continuous
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manner throughout the study protocol. The device sent ECG signals to the Elite HRV mobile
application (Asheville, North Carolina) downloaded to an Apple iPad Pro (Cupertino,
California). In addition, three measures of heart rate variability (HRV) were determined from the
HR signals including the root mean square of successive R-R intervals (RMSSD) (Esco & Flatt,
2014; McNames & Aboy, 2006; Nussinovitch et al., 2011; Thong et al., 2003), low frequency
(LF) HRV, and high frequency (HF) HRV. Respiration rate (RR), or the frequency of inhalations
and expirations during a specified time interval was derived from the Polar ECG signals and was
utilized for analyses of respiration rate reactivity. Kubios HRV Premium version 3.5.0 software
was used to examine HR data for clarity and for HRV calculation (Niskanen et al., 2004).
Actigraphy (ACTIG)
Actigraph wrist watches or “actiwatches” (Phillips Respironics/Model AW-64) were used
to obtain objective measures of sleep parameters including bedtime, sleep onset latency (SOL),
number of nighttime awakenings (NNA), total duration of nighttime awakenings (WASO), wake
time, time in bed (TIB), terminal wakeful time (TWT), total sleep time (TST), and sleep
efficiency (SE). Participants wore the actiwatch on their non-dominant wrists continuously for 3
consecutive days/nights, and data was analyzed to obtain both a 3-night average/habitual value
and a prior (i.e., prior to the day of the virtual stress task session) night value for each sleep
parameter. Actiwatches were only to be removed if the participant anticipated exposure to water
(e.g., taking a shower, swimming, or washing dishes) or if the participant engaged in vigorous
physical activity (e.g., playing sports). Actiware version 6.0.9 software was utilized to analyze
actigraphy data (Philips North America Corporation; Andover, Massachusetts). Self-reported
sleep parameters obtained from an electronic sleep diary (See Sleep Diary and Daily Habits

SLEEP AND CARDIOVASCULAR REACTIVITY

18

Assessment) were utilized to inform sleep time markers during actigraphy data analysis (e.g.,
sleep and wake times).
Self-Report Measures
Demographic Form
A brief demographic form used in previous studies in this laboratory was also utilized
and updated for the current study (e.g., Stephenson, 2015). Questionnaire items inquire about
age, sex and gender identity, sexual orientation, race/ethnicity, height, weight, family
socioeconomic status, and year in school, as well as health status and health behaviors (See
Appendix B).
Pittsburgh Sleep Quality Index (PSQI)
The PSQI (Buysse et al., 1998) is a 19-item questionnaire which assesses self-reported
sleep quality and disturbances over the past month. Responses to each item generate seven
component scores for various sleep parameters including subjective sleep quality, sleep latency,
sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and
daytime dysfunction. Component scores may range from a scale of 0 to 3, with “0” indicating no
difficulty with a particular sleep parameter and “3” indicating severe difficulty. The sum of these
component scores generates a global score for the questionnaire, which ranges from 0-21.
Greater global scores indicate greater sleep difficulty or poorer sleep quality. Psychometric
properties of internal homogeneity and performance consistency have been demonstrated to be
good. The seven component scores of the scale demonstrated a Cronbach’s alpha of 0.83 (Buysse
et al., 1998). The test-retest reliability correlation for global PSQI scores over an average retest
interval of 28.2 days was 0.85 (p < 0.001). Evidence for validity of PSQI scores has been
established as global PSQI scores of greater than “5” showed a sensitivity of 89.6% and
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specificity of 86.5% (kappa = 0.75, p < 0.001) in identifying someone as a “good” or “poor”
sleeper (See Appendix B).
Morningness-Eveningness Questionnaire (MEQ)
The MEQ (Horne & Ostberg, 1976) is a 19-item self-report questionnaire which assesses
the preferred and habitual timing of sleep, physical activity, and alertness at certain times of day.
The MEQ employs both 4-point Likert-type scale as well as a time-scale. The time scales are 7
hours in duration (e.g., 5am to 12pm) and are divided into 15-minute increments, with various
sections assigned scores between 1 and 5. The lowest values of the Likert-type scales indicate
definite eveningness. Total global scores range from 16 to 86, with lower scores indicating
tendency towards evening type, and higher scores indicating tendency towards morning type.
Those who score less than 31 or greater than 69 are considered extreme evening or extreme
morning types, respectively. Internal consistency for the MEQ is good (Cronbach’s alpha = 0.82;
Smith, et al., 1989). The MEQ has demonstrated convergent validity with oral temperature
curves, as morning types tend to have an earlier circadian peak as compared to evening types and
tend to have a higher daytime temperature and lower post circadian peak temperature. Studies
that assessed core body temperature and dim light melatonin onset in participants without
circadian rhythm disorders found that those with a later circadian phase generally scored lower
on the MEQ (Sack et al., 2007) (See Appendix B).
Sleep Diary and Daily Habits Assessment
Participants were asked to complete an electronic sleep diary and daily habits assessment
for each night of study participation via Qualtrics. Just before bedtime during each night of the
study, participants rated their feelings of fatigue for the day on a scale of 0 to 100, with 0
indicating feelings of extreme fatigue and 100 indicating feeling very energetic. Participants also
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indicated whether they took a nap (and duration of nap), whether they consumed alcohol, and
what medications they consumed during that day (if any). Additionally, participants were asked
to answer questions pertaining to their behaviors during the day (over the past 24 hours)
including caffeine use, engagement in physical activity/exercise, and daily stress ratings.
Physical activity items were derived from the International Physical Activity Questionnaire Short
Form (IPAQ-SF) and modified to refer to the past 24 hours (Craig et al., 2003; Lee et al., 2011).
Each morning, participants then reported their bedtime, sleep onset latency, number of nighttime
awakenings, total duration of nighttime awakenings, actual morning wake time and desired wake
time. Data from the sleep diary was used to calculate self-reported time in bed, terminal wakeful
time, total sleep time, as well as sleep efficiency. (See Appendix B).
Karolinska Subjective Sleepiness Scale (KSS)
The KSS (Akerstedt & Gillberg, 1990) is a 1-item scale which asks the responded to rate
his or her subjective level of sleepiness experienced in the last 10 minutes on a scale of 1-9, with
“1” indicating “extremely alert” and “9” indicating “extremely sleepy- fighting sleep.” Higher
scores suggest more sleepiness. Kaida and colleagues (2006) determined that the KSS
demonstrated high validity in measuring sleepiness as it was strongly associated with EEG and
behavioral variables related to a psychomotor vigilance and alpha attenuation test. The KSS has
been shown to correlate strongly with time of day and number of hours passed since awakening
(See Appendix B). The KSS differs from the Epworth Sleepiness Scale (ESS) (Johns, 1991), as
the KSS measures state or instantaneous sleepiness, and the ESS measures trait or habitual
sleepiness. The nature of the correlation between these two measures has not been reported in the
literature.
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Positive and Negative Affect Schedule (PANAS)
The PANAS (Watson et al., 1988) is a 20-item self-report questionnaire that asks the
participant to indicate how they feel in the present moment, utilizing a 5-point Likert-type scale
ranging from 1 (very slightly or not at all) to 5 (extremely). Ten items measure negative affect
(NA) (e.g., scared, hostile, nervous) and ten items measure positive affect (PA) (e.g., interested,
proud, strong). Psychometric evaluation of the PANAS by Watson, Clark, and Tellegen (1988)
revealed moderately good reliability and validity. Regarding internal consistency, Cronbach’s
alpha coefficients for the PA scale have ranged from 0.86 to 0.90, and 0.84 to 0.87 for the NA
scale. Test-retest reliability correlations over a 1-week retest interval were .79 for PA and .81 for
NA, and over an 8-week interval ranged from 0.47-0.68 for PA and 0.39-0.71 for NA. Watson,
Clark, and Tellegen (1988) also found good external validity for the scale, as it is highly
correlated with measures of distress and general psychopathology (NA = .74, PA= -.19), state
anxiety (NA = .51, PA = -.35) and depression (NA = .58, PA = -.36), as measured by the
Hopkins Symptom Checklist (HSCL), Beck Depression Inventory (BDI), and STAI State
Anxiety Scale (A-State) over the past few weeks, respectively (See Appendix B).
Post-Task Questionnaire
The post-task questionnaire asks the participant to report the degree of emotion
experienced during the experimental tasks, perceived difficulty of the tasks, semantic attributions
of the tasks, and other factors related to the participants’ task experiences (See Appendix B).
Experimental Tasks
Each participant engaged in two stress tasks (with task order counterbalanced across
participants) during the virtual stress task protocol.
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Mental Arithmetic Task
Participants were asked to complete a three-minute mental arithmetic task involving the
addition and subtraction of double-digit numbers (e.g., 17 + 24 – 19 = ?). Participants were
allotted 15 seconds to solve each math problem and provide their response aloud. Ten mental
arithmetic problems were presented during the three-minute period. The participant was
instructed to work as quickly and accurately as possible. Previous studies which have
implemented mental arithmetic as a stressor have demonstrated that the task elicits increases in
HR compared to baseline/resting measures (e.g., Langewitz & Rüddel, 1989; Turner et al.,
1987).
Raven Progressive Matrices (RPM) Task
Participants were asked to complete a series of 10 RPM items during a three-minute
period. RPM are a measure of cognitive ability and consist of a series of diagrams with missing
pieces. Participants were required to select one correct piece which completed the design among
eight different options, and to report their answer aloud (Raven et al., 2004). A previous study
from our laboratory demonstrated that when utilized as a stress task, RPM elicited HR reactivity
(Stephenson, 2018) (See Appendix B for an example of a Raven’s Matrices item).
Experimental Design
The current study is quasi-experimental in design. Participants completed the
demographic and sleep questionnaires via the SONA pre-screen survey, and those who satisfied
the inclusion/exclusion criteria were invited to participate in the daily sleep assessment and
virtual stress task portion of the study. All participants completed both the mental arithmetic
(double digit addition/subtraction) task as well as the Raven’s matrices task, in counterbalanced
order across participants to control for order effects.
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Procedure
Participants were selected from an initial screening sample of undergraduate students
enrolled in psychology courses at West Virginia University. After signing an approved consent
agreement, students completed an initial set of screening questionnaires including the
demographic and health questionnaire and other measures of sleep quality (PSQI and MEQ) via
SONA, an online survey system. Participants who met the study eligibility criteria mentioned
above were invited to participate in the experimental portion of the study. It should be noted that
data collection occurred between November 2020 and June 2021, a time when the United States
was responding to the COVID-19 pandemic. The laboratory protocol and the study design were
modified to ensure proper social distancing between experimenter and participant and that
instrumentation was disinfected following each use. Of note, the method for sleep data collection
did not require modification in response to the pandemic. Methods for collecting HR and HRV
data in real time using a virtual stress session were devised and used (See Tiani, in press).
The experimenter then contacted potential participants to inquire about interest in
completing the sleep assessment and virtual stress task portion of the current study. The
experimenter identified a time to meet with interested students to provide them with their virtual
study kit which included one Polar H10 chest monitor, one actiwatch, several alcohol swabs,
electrode gel, and a packet of information regarding study procedures and participant
responsibilities before, during, and after the virtual Zoom© task (e.g., wearing the actiwatch for 3
consecutive days, completing sleep diaries, etc.) The experimenter reviewed this packet of
information as well as answered any questions about the informed consent agreement during this
meeting. Both experimenter and participant wore appropriate face coverings during this meeting
and maintained a six-foot distance from one another. Finally, the exact timing of data collection
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and the scheduling of the virtual stress task session was established as well as a plan for
returning study apparatuses to the experimenter.
Sleep Assessment Phase
Participants wore the actiwatch and completed the daily sleep and habits questionnaire
for three consecutive days. At bedtime on each of these days, participants completed the evening
portion of the electronic sleep diary on a computer, tablet, or smart phone. All participants were
asked to wear the actiwatch for sleep measurement on weeknights only (i.e., not Friday and
Saturday nights), so as to avoid the potential influence of “social jetlag” or delayed sleep
schedules on weekend nights. Participants were asked to begin wearing the actiwatch at least 2
hours prior to going to sleep on the first night of the study, which typically was within one to
three days of when they picked up their study kits. Participants met with the experimenter to pick
up their study kit on a Friday and began the sleep assessment on either Sunday, Monday, or
Tuesday of the following week. Thus, stress task protocols were conducted on Wednesdays,
Thursdays, and Fridays depending on the day of the participant’s first night of sleep assessment.
During the study period, participants were asked to maintain their natural sleep/wake schedule
and to confine their sleep to nocturnal sleep, except for brief naps during the day. Participants
were also asked to avoid nights of complete sleep deprivation during the study. Upon waking
from sleep during the three-day protocol, participants completed the morning portion of the sleep
diary. The participants wore the actiwatch continuously throughout the three-day period and
completed the evening part of the sleep diary and daily health behavior assessment in the
evening for three consecutive nights.

SLEEP AND CARDIOVASCULAR REACTIVITY

25

Virtual Stress Task Session
During the daytime after the third night, the participants logged onto Zoom© (San Jose,
CA, United States) to meet with the experimenter for the Virtual Stress Task Session, lasting
approximately 45 minutes. Approximately half of the participants (n = 24; 21 females, 3 males)
met with a male experimenter, and the other half (n = 26; 23 female, 2 male, 1 other) met with a
female experimenter. Prior to logging into Zoom©, participants were instructed to download the
Elite HRV application to their Bluetooth enabled device and attach the Polar monitor to their
chests.
Once both the experimenter and participant joined the Zoom© meeting, the experimenter
greeted the participant and ensured that the participant was located in a private, distraction-free
environment. The experimenter then confirmed completion of the actiwatch and sleep diary sleep
data collection. The experimenter also confirmed that the participant had not consumed alcohol,
caffeine, nicotine, or any other recreational or illicit substances, or engaged in vigorous exercise
for the past two hours to eliminate the possibility that HR would change across the stress
protocol as a result of these factors. Next, the experimenter asked for the participant’s verbal
consent that they agreed to participate in the virtual Zoom© portion of the study. If the person
consented to participate, they logged into the Elite HRV app on their device with the login
information provided by the experimenter and confirmed Bluetooth pairing. The participant then
completed the KSS questionnaire. Next, a one-minute test recording was conducted to ensure
signal clarity between the Polar monitor and Elite HRV. Then, the experimenter began the virtual
stress protocol.
The participant was asked to begin a continuous HR recording on the Elite HRV app, and
a new recording was started for each respective period of the virtual stress task session (i.e.,
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baseline, task one, rest, task two, and recovery). During the five-minute baseline, the participant
was asked to sit upright in a chair with their feet placed flat on the floor and to minimize bodily
movement. During the five-minute baseline period, participants sat quietly and watched a fiveminute nature video entitled Relaxing Island Sounds (BBC Earth;
https://www.youtube.com/watch?v=2QPbriKs_sI).The video was displayed to the participant
from the experimenter’s computer using the screen sharing feature on Zoom©. After the baseline
period ended, the participant completed a baseline PANAS questionnaire via a Qualtrics link
which was sent to them via the chat function in Zoom©. Next, the first stress task began.
Participants completed both a mental arithmetic task as well as a Raven’s matrices task, in
counterbalanced order across participants. For the two stress tasks, the experimenter again used
the screen-sharing feature to display a series of slides to the participant. For the mental arithmetic
task, each slide included a double-digit addition and subtraction problem to solve, and for the
Raven’s matrices task, each slide contained a pattern with a missing piece and possible answer
choices below. Instructions for each task were provided that included a sample item, and any
questions about how to complete the task were answered prior to beginning each task. Each
stress task lasted three minutes. After completion of the first stress task, the participant
completed a Task 1 PANAS questionnaire, and then underwent a five-minute recovery/rest
period. Then, the participant completed the second stress task, followed by a Task 2 PANAS
questionnaire. Finally, the participant underwent a five-minute recovery/rest period.
At the end of the protocol, participants were asked to remove the Polar monitor and
actiwatch and were then debriefed by the experimenter. The participant was asked to return the
laboratory equipment (Polar monitor, actiwatch) within 2-3 days after completing the protocol.
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Once the equipment was returned to the experimenter in person, the participant received a
payment of $25 via a prepaid Mastercard.
Data Analysis
Physiological Data Cleaning (HR) and Reduction
Heart rate data and interbeat intervals (IBIs) were inspected for abnormal data points and
artefacts, or extreme deviations from the pattern of IBIs using the automatic artefact correction
algorithm in the Kubios Premium HRV v5.0.0 software (Lipponen & Tarvainen, 2019). This
version of the Kubios software also included a noise detection algorithm which detects and
excludes data from HRV analyses where HR signal quality significantly fluctuates, allowing for
a more accurate representation of these parameters. After correction, mean HRs were calculated
for each minute of the baseline, task, and rest periods, respectively. Heart rate data was also
averaged for each protocol period (e.g., baseline, mental arithmetic task, mental arithmetic
recovery period, Raven’s matrices task, and Raven’s matrices recovery period).
Measures of HR reactivity to the stress tasks were generated by calculating the average
HR across the three-minute task period for both the mental arithmetic and Raven’s matrices
tasks. A single measure of HR reactivity to stress was calculated by averaging standardized
residualized change scores of both the mental arithmetic and Raven’s matrices tasks.
Standardized residualized change scores permit combining HR reactivities across different tasks
while controlling for pre-task baselines (Manuck et al., 1989).
HR recoveries for both mental arithmetic and Raven’s matrices tasks were determined by
calculating area under the curve (AUC) during each recovery period. The following formula was
used: Excursion = (0.5*60) [(Last minute task HR + (2*HR at recovery min 1) + HR at recovery
min 2)] - (HR at baseline*120). This formula has been used in several previous studies of
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cardiovascular recovery (Friedberg et al., 2007; Neumann et al., 2004; Whited et al., 2010).
Larger AUC values indicate a prolonged recovery time compared to smaller AUC values. Like
reactivity measures, AUCs were converted to standardized scores and averaged to obtain a single
measure of HR recovery for each participant.
Measures of HRV and ECG-derived respiration were analyzed for each protocol period
using Kubios software for conducting the spectral analyses of interbeat intervals from HR data.
Kubios version 3.5.0 includes a respiratory rate estimation algorithm that has been validated
(Lipponen & Tarvainen, 2021). Three measures of HRV were determined for use in the proposed
study: HF-HRV, LF-HRV, and RMSSD. While the importance of controlling for the influence of
respiration rate is contested in the literature, some researchers argue that it exerts a significant
influence on HRV and that controlling for it provides a more accurate estimate of HRV
(Grossman & Taylor, 2007; Porges, 2007). In the proposed analyses it was reported that a
significant difference in respiration rate between rest and task periods would be statistically
controlled for by utilizing the standardized residual method to remove the influence of resting
respiration rate. We realized, however, that this method would only control for resting respiration
rate and not change in respiration rate in response to the task. Therefore, we decided to conduct
the main analyses without controlling for respiration rate, and, if significant associations between
sleep parameters and HRV reactivity appeared, respiration would be added as a predictor
variable in subsequent regression analyses to see if it altered the finding. Regression analyses to
see whether sleep predicted respiration rate reactivity alone were also conducted, as respiration
rate is coupled with measures of cardiovascular functioning (Cheifetz, 2014; Grossman, 1983).
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Sleep Data Cleaning (Actigraphy) and Reduction
Actigraphy data was recorded and stored in 15-second epochs, and was exported into
Philips Actiware Version 6.0.9 (Philips Respironics) software and visually inspected and scored
using The Multi-Ethnic Study of Atherosclerosis (MESA) actigraphy scoring guidelines (Ogilvie
et al., 2016). Sleep/wake event markers, self-reported sleep diary data, and visual inspection of
activity levels were used to manually indicate rest intervals. To mark the start of a rest interval, if
a sleep event marker was available and within 15 minutes of activity count drop off, the sleep
event marker was used as the start of the rest interval. If the sleep event marker was not available
or not within 15 minutes of activity level drop-off, sleep diary data was considered. If the sleep
diary sleep onset time was within 15 minutes of the activity count drop off and the sleep time
occurred before the activity count drop off time, the sleep diary time was used as the start time of
the rest onset interval. If the sleep diary time was not within 15 minutes of the activity count
drop off, the activity count drop off time was used as the start of the rest onset interval. The same
protocol was used to mark the end of the rest interval, using activity level increases instead of
drop offs and using sleep diary data as the end time of the rest interval only if the sleep diary
time was within 15 minutes of the activity level increase and occurred after the activity level
increased. Self-reported time periods when the participant was not wearing the watch (e.g.,
“watch off” times during showering, swimming, etc.) were excluded from analyses so as not to
be mistaken for periods of rest.
After the rest intervals were indicated, the Actiware software, which employs a validated
algorithm (Oakley, 1997), was used to estimate sleep parameters within the manually designated
sleep intervals. A medium wake detection threshold of 40.0 activity counts per 15-second epoch
was utilized. Thus, depending on the activity count value, each epoch was classified as either
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sleep or wake. The sleep detection threshold was configured such that the participant was
presumed to be asleep after 10 continuous minutes of immobility/inactivity.
Values for bedtime, sleep onset latency (SOL), number of nighttime awakenings (NNA),
total duration of nighttime awakenings (WASO), wake time, time in bed (TIB), terminal wakeful
time (TWT), total sleep time (TST), and sleep efficiency (SE) were calculated for each of the
three study nights, and a measure of habitual sleep was created by calculating the average value
for each parameter across the three nights. Each of these values for the night preceding the
virtual stress task sessions was also examined to assess whether sleep effects on cardiovascular
reactivity were differentially associated based on proximity to the reactivity assessment.
The two sleep parameters of primary interest were total sleep time and sleep efficiency;
however, it is recognized that although these are the two parameters shown to be most
consistently related to CVR in the literature (Castro-Diehl et al., 2016; Chen et al., 2017; Mezick
et al., 2014), other measured sleep parameters may exhibit stronger associations with CVR in
this sample. Thus, a univariate correlation matrix between all sleep parameters and measures of
CVR was constructed to verify that total sleep time and sleep efficiency exhibited the strongest
associations with CVR and to identify any other potential sleep parameters associated with CVR
(See Table C.9).
Results
Prior to conducting the primary analyses of interest, distributions were examined to
ensure the data did not violate the assumptions of multiple linear regression (e.g., linearity,
normality, multicollinearity, and homoscedasticity). As no covariates were identified (e.g., MEQ
chronotype scores, BMI, etc.; See Appendix C) the predictor variables of interest, total sleep
time and sleep efficiency were entered directly in step 1.
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A series of preliminary analyses was conducted to examine reactivity during rest and task
periods, differences between the two experimenters, and any task order effects. (See Appendix
C, D, and E for a description of these analyses). Significant experimenter effects were observed
for measures of average task HF-HRV and self-reported feelings of being upset by task
performance; participants who interacted with Experimenter A exhibited greater HF-HRV
reactions (i.e., more vagal response to stress) and reported being more upset than participants
who interacted with Experimenter B. Significant Task Order effects were observed for selfreported feelings of stress during the task. Participants who completed the mental arithmetic task
prior to the Raven's matrices task reported less stress than those who completed the Raven's
matrices task prior to mental arithmetic. As assignment to experimenter and task order was
counterbalanced across participants, experimenter and task order were not controlled for in the
primary analyses.
Total Sleep Time and Sleep Efficiency as Predictors of Physiological Reactivity to Tasks
For each measure of physiological reactivity to mental stress, two multiple linear
regression analyses were conducted with the sleep parameters of TST and SE as predictors and
measures of physiological reactivity to the stress tasks as criterion variables. One regression
analysis used sleep parameters averaged over all three days and the other used sleep parameters
from the night prior to the virtual stress testing session.
Heart Rate. Three-day average TST and SE were not found to be significant predictors of
average task HR reactivity, F(2, 47) = 1.65, p = .20, R2 = .07. Prior night TST and SE were also
not found to be significant predictors of average task HR reactivity, F(2, 47) = .021, p = .98, R2 =
.00.
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Root Mean Square of Successive Differences (between normal heartbeats). Three-day
average TST and SE were not found to be significant predictors of average task RMSSD
reactivity, F(2, 47) = .421, p = .66, R2 = .02. Prior night TST and SE were also not found to be
significant predictors of average task RMSSD reactivity, F(2, 47) = .209, p = .81, R2 = .01.
High Frequency Heart Rate Variability. Three-day average TST and SE were not found
to be significant predictors of average task HF-HRV reactivity, F(2, 47) = .267, p = .77, R2 = .01.
Prior night TST and SE were also not found to be significant predictors of average task HF-HRV
reactivity, F(2, 47) = .062, p = .94, R2 = .00.
Low Frequency Heart Rate Variability. Three-day average TST and SE were not found
to be significant predictors of average task LF-HRV reactivity, F(2, 47) = .473, p = .63, R2 = .02.
Prior night TST and SE were also not found to be significant predictors of average task LF-HRV
reactivity, F(2, 47) = 1.40, p = .26, R2 = .06.
Respiration Rate. Three-day average TST and SE were not found to be significant
predictors of average task respiration rate reactivity, F(2, 47) = .121, p = .89, R2 = .01. Prior
night TST and SE were also not found to be significant predictors of average task respiration rate
reactivity, F(2, 47) = .631, p = .54, R2 = .03.
Total Sleep Time and Sleep Efficiency as Predictors of Heart Rate Recovery from Tasks
A pair of multiple linear regressions was conducted to examine whether three-day
average TST and SE as well as prior night TST and SE were significant predictors of heart rate
recovery (AUC) from the stress task periods. Three-day average TST and three-day average SE
were not significant predictors of HR recovery, F(2, 47) = 1.31, p = .28, R2 = .05, nor were prior
night TST and SE found to be significant predictors, F(2, 47) = .98, p = .38, R2 = .04.
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Total Sleep Time and Sleep Efficiency as Predictors of Affective Reactivity
A series of multiple linear regression analyses was conducted to determine whether threeday average and prior night TST and SE would significantly predict changes in positive and
negative affect in response to the stress tasks. Three-day TST and SE did not significantly predict
average task positive affect reactivity, F(2, 46) = .43, p = .65, R2 = .02, nor average task negative
affect reactivity, F(2, 46) = 2.00, p = .15, R2 = .08. Prior night TST and SE also failed to
significantly predict average task positive affect reactivity, F(2, 46) = .86, p = .43, R2 = .04, as
well as average task negative affect reactivity, F(2, 46) = .86, p = .43, R2 = .04.
Total Sleep Time and Sleep Efficiency as Predictors of Self-Reported Task Appraisals
Another series of multiple linear regression analyses was conducted to determine whether
three-day average and prior night TST and SE would significantly predict self-reported stress
task appraisals.
“How stressful was the task?” Three-day average TST and SE were significant
predictors of average task stress ratings, F(2, 46) = 3.68, p < .05, R2 = .14. Decreases in threeday average SE were significantly associated with higher stress ratings, β = -0.38, p < .05. Threeday average TST was not a significant independent predictor of stress ratings, β = 0.30, p = .053.
To explore task differences in stress ratings, a pair of multiple linear regressions revealed that
three-day average TST and SE significantly predicted Raven task stress ratings, F(2, 47) = 3.64,
p < .05, R2 = .13, but did not significantly predict math task stress ratings, F(2, 46) = 1.25, p =
.30, R2 = .05. For the Raven task, decreases in three-day SE were significantly associated with
increased task stress ratings, β = -0.38, p < .05, while three-day TST was not, β = 0.29, p = .057.
Prior night TST and SE were not found to be significant predictors of average task stress ratings,
F(2, 46) = 1.06, p = .36, R2 = .04.
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“How difficult were the problems on this task?” Three-day average TST and SE were
not found to be significant predictors of average task difficulty ratings, F(2, 46) = 1.71, p = .19,
R2 = .07, and prior night TST and SE were also not significant predictors of perceived task
difficulty, F(2, 46) = 1.50, p = .24, R2 = .06.
“How hard did you try to complete the problems?” Three-day average TST and SE were
not found to be significant predictors of average task effort ratings, F(2, 46) = 0.44, p = .65, R2 =
.02, and prior night TST and SE were also not significant predictors of effort, F(2, 46) = .16, p =
.86, R2 = .01.
“How well do you think you performed on the task?” Three-day average TST and SE
were not found to be significant predictors of average task performance ratings, F(2, 46) = 2.56,
p = .09, R2 = .10, and prior night TST and SE were also not significant predictors of
performance, F(2, 46) = 2.95, p = .06, R2 = .11.
“How persistent were you in completing the task?” Three-day average TST and SE were
significant predictors of average task persistence ratings, F(2, 46) = 3.96, p < .05, R2 = .15.
Increases in three-day average TST were significantly associated with higher persistence ratings,
β = 0.40, p < .05. Three-day average SE was not a significant independent predictor of
persistence ratings, β = -0.28, p = .07. To examine task differences in persistence ratings, a pair
of multiple linear regressions revealed that three-day average TST and SE significantly predicted
Raven task persistence ratings, F(2, 47) = 4.06, p < .05, R2 = .15, but did not significantly predict
math task persistence ratings, F(2, 46) = 1.68, p = .20, R2 = .07. Increases in three-day TST were
significantly associated with increased Raven task persistence ratings, β = 0.38, p < .05, while
three-day SE was not, β = -0.30, p = .051. Prior night TST and SE were not found to be
significant predictors of average task persistence ratings, F(2, 46) = 2.00, p = .15, R2 = .08.
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“How upset are you by your performance on the task?” Three-day average TST and SE
were not found to be significant predictors of average task ratings of feeling upset, F(2, 46) =
1.19, p = .31, R2 = .05, and prior night TST and SE were also not significant predictors of feeling
upset, F(2, 46) = .05, p = .95, R2 = .00.
Wake After Sleep Onset as a Predictor of Physiological Reactivity to Tasks
All sleep and cardiovascular reactivity parameters were entered into a correlation matrix
to determine whether measured sleep indices might be more strongly correlated with reactivity
outcomes than three-day average and prior night TST and SE. Results indicated a significant
positive correlation between three-day average WASO and average HR reactivity, as well as
significant negative correlations between three-day average WASO and average RMSSD and HF
(all p < .05). Prior night WASO was also significantly negatively correlated with RMSSD (p <
.05) (See Table C.8). These results suggested that the duration of sleep disruptions or
awakenings might be more strongly correlated with measures of reactivity than the total duration
of sleep obtained or sleep efficiency. Considering the significant correlations between WASO
and several measures of CVR, it was decided that in addition to the originally proposed primary
analyses utilizing three-day average and prior night TST and SE as predictor variables, a series
of simple linear regressions would be conducted to examine WASO as a predictor of task
reactivity.
This section details the results of a series of simple linear regressions in which three-day
average WASO and prior night WASO are utilized as separate predictors of physiological
reactivity to the stress tasks.
Heart Rate. A simple linear regression was conducted to predict average task HR
reactivity based on three-day average WASO. The overall regression equation was statistically
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significant, F(1, 48) = 5.55, p < .05, R2 = .10. The standardized regression coefficient, β = 0.32, p
< .05, indicated that an increase in three-day average WASO was significantly associated with an
increase in average task HR reactivity. To assess task differences, two additional simple linear
regressions were conducted with three-day average WASO as a predictor of math task HR
reactivity and Raven task HR reactivity, respectively. Three-day WASO was a significant
predictor of Raven task HR reactivity, F(1, 48) = 7.57, p < .01, R2 = .14, and increases in threeday average WASO were significantly associated with increased Raven task HR reactivity, β =
0.34, p < .01. Three-day average WASO was not a significant predictor of math task HR
reactivity, F(1, 48) = 1.75, p = .20, R2 = .04.
A second linear regression was conducted to predict average task HR reactivity based on
prior night WASO and prior night WASO did not explain a significant amount of the variance in
HR reactivity, F(1, 48) = 3.27, p =.08, R2 = .06.
Root Mean Square of Successive Differences (between normal heartbeats). A simple
linear regression was conducted to predict average task RMSSD reactivity based on three-day
average WASO. The overall regression equation was statistically significant, F(1, 48) = 5.95, p <
.05, R2 = .11. The standardized regression coefficient, β = -0.33, p < .05, indicated that an
increase in three-day average WASO was significantly associated with a decrease in average task
RMSSD reactivity, reflecting reduced vagal activity during stress. To assess for individual task
differences, two additional simple linear regressions were conducted with three-day average
WASO as a predictor of math task RMSSD reactivity and Raven task RMSSD reactivity,
respectively. Three-day WASO was a significant predictor of Raven task RMSSD reactivity,
F(1, 48) = 4.64, p < .05, R2 = .09, and increases in three-day average WASO were significantly
associated with decreased Raven task RMSSD reactivity, β = -0.30, p < .05. Three-day average
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WASO was not a significant predictor of math task RMSSD reactivity, F(1, 48) = 3.21, p = .08,
R2 = .06.
A second linear regression was conducted to predict average task RMSSD reactivity
based on prior night WASO and prior night WASO explained a significant amount of the
variance in RMSSD reactivity, F(1, 48) = 4.80, p < .05, R2 = .09, Increases in prior night WASO
were associated with decreased average task RMSSD reactivity, β = -0.30, p < .05. Two
additional simple linear regressions were conducted to assess for task differences, with priornight WASO as a predictor of math task RMSSD reactivity and Raven task RMSSD reactivity,
respectively. Prior night WASO was a significant predictor of math task RMSSD reactivity, F(1,
48) = 4.44, p < .05, R2 = .09, and increases in prior night WASO were significantly associated
with decreased math task RMSSD reactivity, β = -0.30, p < .05. Prior night WASO was not a
significant predictor of Raven task RMSSD reactivity, F(1, 48) = 2.12, p = .15, R2 = .04.
As three-day average and prior night WASO were each revealed to be significant
predictors of RMSSD reactivity, two follow-up hierarchical regression analyses utilizing the
average residualized respiration rate change score as a covariate in step 1 and three-day or prior
night WASO in step 2 were conducted to determine the influence of change in respiration rate on
these findings. For three-night WASO, at step 1, results revealed that respiration reactivity alone
was not a significant predictor of average RMSSD reactivity, F(1, 48) = .861, p = .36, R2 = .02.
At step 2 three-day WASO was added, and the model was significant, F(2, 47) = 3.38, p < .05,
R2 = .13. The two-variable equation explained 12.6% of the variance in RMSSD reactivity, with
10.8% uniquely explained by three-day WASO, which had a significant F change value p < .05.
For prior night WASO, results revealed that the first model with respiration reactivity alone was
not significant, F(1, 48) = .861, p = .36, R2 = .02, and when prior night WASO was added in step
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2, the model was not significant, F(2, 47) = 2.99, p = .06, R2 = .11. Though the two-variable
equation was not significant, it explained 11.3% of the variance in RMSSD reactivity, 9.5% of
which was uniquely accounted for by prior night WASO, with a significant F change value of p
< .05. This pattern of findings showed that increased WASO was associated with lower RMSSD
reactivity to mental stress, but the strength of this association was influenced by changes in
respiration in response to mental stress.
High Frequency Heart Rate Variability. A simple linear regression was conducted to
predict average task HF-HRV reactivity based on three-day average WASO. The overall
regression equation was statistically significant, F(1, 48) = 4.93, p < .05, R2 = .09. Like RMSSD,
the standardized regression coefficient, β = -0.31, p < .05, indicated that an increase in three-day
average WASO was significantly associated with a decrease in average task HF-HRV reactivity,
also reflecting reduced vagal activity during stress. To assess for individual task differences, two
additional simple linear regressions were conducted with three-day average WASO as a predictor
of math task HF-HRV reactivity and Raven task HF-HRV reactivity, respectively. Interestingly,
three-day WASO was not shown to be a significant predictor of Raven task HF-HRV reactivity,
F(1, 48) = 3.80, p = .06, R2 = .07, or math task HF-HRV reactivity, F(1, 48) = 2.42, p = .13, R2 =
.05, in the individual analyses. A second linear regression was conducted to predict average task
HF-HRV reactivity based on prior night WASO and prior night WASO was not a significant
predictor of HF-HRV reactivity, F(1, 48) = 3.85, p = .056, R2 = .07.
As three-day average WASO was revealed to be a significant predictor of HF-HRV
reactivity, a follow-up hierarchical regression analysis utilizing the average residualized
respiration rate change score as a covariate in step 1 and three-day WASO in step 2 was
conducted to determine the influence of change in respiration rate on these findings. At step 1,
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results revealed that respiration reactivity alone was a significant predictor of average HF-HRV
reactivity, F(1, 48) = 4.54, p < .05, R2 = .09. When three-day WASO was added in Step 2, the
model was still significant, F(2, 47) = 4.99, p < .05, R2 = .18. The two-variable equation
explained 17.5% of the variance in HF-HRV reactivity, with 8.9% uniquely explained by threeday WASO, with a significant F change value of p < .05. These results indicate that the
association between WASO and HF-HRV reactivity to stress persists even when controlling for
change in respiration to mental stress.
Low Frequency Heart Rate Variability. A simple linear regression was conducted to
predict average task LF-HRV reactivity based on three-day average WASO. The overall
regression equation was not statistically significant, F(1, 48) = 1.10, p = .30, R2 = .02. A second
linear regression was conducted to predict average task LF-HRV reactivity based on prior night
WASO and prior night WASO was not a significant predictor of LF-HRV reactivity, F(1, 48) =
.21, p = .65, R2 = .00.
Respiration Rate. A simple linear regression was conducted to predict average task
respiration rate reactivity based on three-day average WASO. The overall regression equation
was not statistically significant, F(1, 48) = .15, p = .70, R2 = .00. A second linear regression was
conducted to predict average task respiration rate reactivity based on prior night WASO and
prior night WASO was not a significant predictor of respiration rate reactivity, F(1, 48) = .07, p
= .80, R2 = .00.
Wake After Sleep Onset as a Predictor of Heart Rate Recovery from Tasks
A pair of simple linear regressions was conducted to examine whether three-day average
WASO and prior night WASO were significant predictors of heart rate recovery (AUC) from the
stress task periods. Three-day average WASO was not a significant predictor of HR recovery,
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F(1, 48) = .66, p = .42, R2 = .01, nor was prior night WASO found to be a significant predictor,
F(1, 4) = .05, p = .883, R2 = .00.
Wake After Sleep Onset as a Predictor of Affective Reactivity
A pair of simple linear regression analyses was conducted to determine whether three-day
average and prior night WASO would significantly predict changes in positive and negative
affect in response to the stress tasks. Three-day WASO did not significantly predict average task
positive affect reactivity, F(1, 47) = .09, p = .76, R2 = .00, nor average task negative affect
reactivity, F(1, 47) = .97, p = .33, R2 = .02. Analyses revealed that prior night WASO was also
not a significant predictor of average task positive affect reactivity, F(1, 47) = .05, p = .83, R2 =
.00, nor was average task negative affect reactivity, F(1, 47) = .68, p = .41, R2 = .01.
Secondary Analyses: Wake After Sleep Onset as a Predictor of Self-Reported Task
Appraisals
Simple linear regression analyses were conducted to determine whether three-day
average WASO and prior night WASO were significantly associated with self-reported task
appraisals.
“How stressful was the task?” Three-day average WASO was not found to be a
significant predictor of average task stress ratings, F(1, 47) = 1.91, p = .17, R2 = .04, nor was
prior night WASO, F(1, 47) = 1.85, p = .18, R2 = .04.
“How difficult were the problems on this task?” Three-day average WASO was not
found to be a significant predictor of average task difficulty ratings, F(1, 47) = 0.72, p = .40, R2 =
.02, nor was prior night WASO, F(1, 47) = 0.16, p = .69, R2 = .00.
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“How hard did you try to complete the problems?” Three-day average WASO was not
found to be a significant predictor of average task effort ratings, F(1, 47) = 2.98, p = .09, R2 =
.06, nor was prior night WASO, F(1, 47) = 1.68, p = .20, R2 = .04.
“How well do you think you performed on the task?” Three-day average WASO was
not found to be a significant predictor of average task performance ratings, F(1, 47) = 0.01, p =
.92, R2 = .00, nor was prior night WASO, F(1, 47) = 0.17 p = .68, R2 = .00.
“How persistent were you in completing the task?” Three-day average WASO was not
found to be a significant predictor of average task persistence ratings, F(1, 47) = 0.52, p = .47, R2
= .01, nor was prior night WASO, F(1, 47) = 1.52, p = .22, R2 = .03.
“How upset are you by your performance on the task?” Three-day average WASO was
not found to be a significant predictor of average task ratings of feeling upset, F(1, 47) = .44, p =
.51, R2 = .01, nor was prior night WASO, F(1, 47) = 1.37, p = .25, R2 = .03.
Discussion
Studies comprising the literature examining the association between sleep parameters and
cardiovascular reactivity to stress are heterogeneous with regard to specific objective and selfreported measures of sleep, measurement of physiological variables, sample demographics, and
stress-inducing stimuli. Additionally, studies in this literature have reported mixed and
sometimes inconsistent findings. The primary purpose of the current study was to replicate
previous research examining the relation between sleep and cardiovascular reactivity and
recovery to mental stress while accounting for various methodological and statistical
shortcomings of previous studies. Although not an initial study aim, the COVID-19 pandemic
created an opportunity to study this relation within the participants’ natural environments, as
previous studies have examined this relation within a laboratory setting. It was hypothesized that
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decreases in total sleep time and sleep efficiency (i.e., increased sleep disruption) would be
significantly associated with increased CVR to the mental arithmetic and Raven’s matrices stress
tasks. It was also hypothesized that other measures of sleep disruption (e.g., WASO) would be
significantly associated with increased CVR to the stress tasks. With regard to HR recovery from
stress, it was hypothesized that decreases in total sleep time and sleep efficiency would be
significantly associated with prolonged recovery following the stress tasks.
Results of this study did not support the primary study hypotheses, as neither measures of
prior night TST and SE nor measures of three-day average TST and SE were significantly
associated with any measures of CVR, RESP, or AUC/HR recovery. Results did support the
secondary hypothesis, as increases in three-day average WASO were associated with increased
HR reactivity, decreased RMSSD reactivity, and decreased HF-HRV reactivity. The significant
relation between three-day average WASO and measures of CVR was largely accounted for by
reactions to the Raven’s matrices task. In addition, increases in prior night WASO were
significantly associated with decreased RMSSD reactivity, though this was specific only to the
mental arithmetic task. In addition, the strength of the associations between three-day average
WASO and RMSSD was influenced by change in respiration in response to the tasks, but the
association between three-day average WASO and HF-HRV persisted even when controlling for
change in respiration. The observed response profile indicates that a greater duration of
awakenings in the middle of the sleep window was associated with a decreased influence of the
parasympathetic nervous system in response to the stressful stimuli, especially for the Raven’s
matrices task. It was unclear why this pattern was most observed for the Raven’s matrices task,
and perhaps this finding is simply attributed to the fact that participants felt more challenged by
the novelty of the task as compared to the mental arithmetic task.
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As previously mentioned, prior studies examining the relation between CVR and sleep
have resulted in mixed findings. In considering the studies which also utilized objective
measures of sleep (e.g., polysomnography or actigraphy), the majority of prior studies have
found that increased sleep disruption tended to be associated with increased CVR and
sympathetic reactivity to stress as compared to less disrupted sleep. The findings from the
current study are consistent with five studies which found no significant association between
TST and measures of CVR (Brindle et al., 2018; Covassin et al., 2013; Kato et al., 2000; Massar
et al., 2017; Palesh et al., 2008), one study which found no significant association between SE
and CVR (Castro-Diehl et al., 2016), and two studies which found that increased WASO was
associated with decreased parasympathetic/increased sympathetic activity in response to stress
(Covassin et al., 2013; Palesh et al., 2008). In contrast, the current study results were inconsistent
with five studies that found decreased SE was significantly associated with increased
sympathetic and decreased parasympathetic activation in response to stress (Chen et al., 2017;
Covassin et al., 2013; Lustyk et al., 2012; Massar et al., 2017; Palesh et al., 2008), six studies
that found increased hours of sleep deprivation/restriction or decreased TST were associated with
decreased parasympathetic/increased sympathetic reactivity (Castro-Diehl et al., 2016; Chen et
al., 2017; Franzen et al., 2011; Mezick et al., 2014; Yang et al., 2012; Zhong et al., 2005), and
one study that found decreased TST was associated with decreased HR (James & Gregg, 2004).
Of the studies measuring recovery from stress, the majority found significant associations
between decreased TST or SE and delayed or prolonged recovery, while a minority found that
decreased TST and SE were associated with faster return to baseline. Only one previous study
did not detect a significant association. Therefore, the recovery findings from this study are
inconsistent with the majority of results reported in the prior literature.
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It is interesting to consider why measures of WASO were found to be significantly
related to decreased parasympathetic reactivity in this study, but that TST and SE displayed no
significant associations with CVR. Regarding TST, it is possible that this variable is best viewed
as curvilinear versus linear, with an “ideal” TST somewhere between six to eight hours, for
example. A scatterplot was created to visually examine the relation between TST and CVR,
however, no curvilinear relation was detected. Of note, the range of TST values across
participants was a minimum of four hours and a maximum of 8.5 hours, with the majority of
participants (n = 37) obtaining at least six hours of sleep per night. Thus, the range of TST values
may not have been broad enough to accurately test this hypothesis. It is also possible that
because the duration of sleep needed to feel restored varies from person to person, that increased
disruptions in the sleep window, regardless of length of TST, are more salient. This certainly is
in line with the findings that increased WASO was significantly associated with CVR. Perhaps
increased duration and number of awakenings leads to feelings of frustration, anxiety, and
ultimately increased stress, which could in turn blunt the decrease in heart rate typically observed
during sleep. This does not explain, however, why SE was not significantly associated with
CVR, as SE represents the percentage of time in bed spent asleep. SE accounts for awakenings
that occur during the sleep window, such as sleep onset latency (SOL), WASO, and morning
snooze time. WASO specifically refers to periods of wakefulness between the time that sleep is
initiated and the time of final morning awakening. Thus, perhaps these results indicate that
middle of the night awakenings are particularly salient to CVR, but that wakefulness before
(SOL) and after (snooze time) the sleep window is initiated and ended are less relevant. For
example, it is possible that two individuals with the same SE percentage have differing levels of
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sleep disruption due to WASO, SOL, or snooze time. The findings of this study seem to
implicate WASO as the most relevant of the three.
It is also worth noting the lack of significant findings for analyses examining TST, SE
and WASO as predictors of HR recovery (AUC) from stress. A possible reason for the lack of
significant findings is the limited duration of the recovery period. As recovery was only analyzed
across a three-minute time period, it is possible that the full magnitude of recovery was not
captured in such a short time frame. Furthermore, recovery analyses were limited only to the
measure of HR, and it is possible that other measures of cardiovascular recovery may have
shown significant effects if they had been assessed.
Of note, one reason for a lack of significant associations between TST, SE, CVR and
recovery was the decision to screen for all sleep disorders other than insomnia during participant
recruitment. As a result, we may have artificially restricted the range of sleep parameter values
(e.g., TST). Indeed, observed effect sizes for the aforementioned primary analyses were smaller
than anticipated, suggesting that the sample may have been unpowered to detect significant
associations between these variables.
In addition to examining the relation between sleep and CVR, this study also examined
the nature of the associations between sleep measures and self-reported affect and task
appraisals. TST, SE, and WASO were not found to be significantly associated with measures of
positive and negative affect reactivity to either stress task. Regarding task appraisals, decreases
in three-day average SE were significantly associated with higher average task stressfulness
ratings for the Raven’s task specifically, while increases in three-day average TST were
associated with higher average task persistence ratings, also specific to the Raven’s task. No
significant associations were found between WASO and task appraisals. While no specific
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hypotheses were made with regard to task appraisals, the data generally support the notion that
quality of sleep was significantly associated with how the participants perceived the stress tasks.
Experimenter Effects
Results indicated that there was a significant difference in HF-HRV reactivity to the tasks
for participants who interacted with Experimenter A versus Experimenter B. Specifically, HFHRV reactivity was higher when interacting with Experimenter A as compared to Experimenter
B. There was also a significant effect of experimenter on task appraisal, as participants reported
feeling more upset about their performance on the tasks when interacting with Experimenter A as
compared to Experimenter B. In considering the factors that may have influenced these results, it
should be noted that Experimenter A was female and was considered the primary graduate
student experimenter, while Experimenter B was male and was considered the assistant
undergraduate experimenter. Experimenter A had substantially more direct interactions with
participants during data collection as she was responsible for contacting and scheduling
participants as well as meeting them in person for equipment pick up. It is possible that HF-HRV
reactivity was higher when interacting with Experimenter A as compared to Experimenter B
because the participants were more familiar with Experimenter A. Factors influencing ratings of
being upset are somewhat unclear. Perhaps participants reported feeling more upset by their
performance when interacting with Experimenter A because of Experimenter A’s status as the
primary experimenter, or because participants believed they were supposed to perform well on
the tasks. Participants were aware that the project was Experimenter A’s dissertation project. As
such, there may have been a social desirability effect such that the participants wanted to perform
well in the presence of the primary experimenter and became upset if they did not. In contrast,
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social desirability may have been less relevant with Experimenter B who was a novel assistant
experimenter and may have been perceived as less involved with the study.
Task Order Effects
While task order effects were not observed for measures of CVR in response to mental
stress, significant task order effects were observed with regard to the task appraisal of perceived
stressfulness. Specifically, participants who completed task order 2 (Raven followed by math
task) reported higher overall task stress ratings as compared to those who completed task order 1.
Participants were not told what types of cognitive tests they would be asked to complete prior to
the study session, and while most participants have likely been asked to perform mental
arithmetic, it is likely that few to none were as familiar with detecting a series of patterns as
required by the Raven’s task. It is possible that the novelty of the Raven task as compared to the
mental arithmetic task may have led participants to report greater feelings of stress after
completing a novel task first, as compared to completing a novel task after completing a familiar
task (as in task order 1). More specifically, after baseline, being immediately presented with a
familiar math task may have reduced feelings of stress and anxiety and increased confidence as
the participants approached the second, novel task, whereas immediately completing the novel
task may have led to increased feelings of uncertainty about their ability to successfully complete
the study tasks.
Strengths and Limitations
Several strengths of the current study are worth noting. To our knowledge, this study is
one of the first studies of cardiovascular reactivity to utilize live, remote physiological data
collection during an entirely virtual stress task protocol. Though the impetus to conduct a virtual
study was the COVID-19 pandemic, the virtual format is novel in design. In addition, the current
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study measured not only physiological data, but also self-reported affect and task appraisals,
which allowed us to consider the influence of sleep parameters on cognitive and emotional
factors as well as affective reactivity. In addition, the remote nature of the stress task protocol
complemented the remote measurement of sleep data, such that all measurements were
completed in the participant’s home.
Although the study contained various strengths, it also exhibited several weaknesses. An
initial limitation of this study was the use of an undergraduate student sample of men and
women. While the use of this sample provided a wide pool from which to recruit potential
participants, it is important to note how this sample differs from the general population not only
in terms of demographics but in terms of sleep patterns. As previously described, the study
sample was primarily Caucasian, single, and female; thus, results may not be generalizable to
individuals who do not fall into these demographic categories. It is important to note that
although the large percentage of females in our sample is thought to be congruent with the
percentage of females enrolled in undergraduate psychology courses at WVU, the fact that the
sample is primarily female is a significant limitation. The distribution of males and females did
not allow us to investigate whether the nature of our findings differed between males and
females. More specifically, we were not able to analyze gender differences in cardiovascular
reactivity and recovery. This is potentially problematic as the literature suggests that there are
gender differences in resting HR and BP and HR and BP reactivity. Specifically, females tend to
have higher resting HR and slightly higher HR reactivity as compared to males, while males
exhibit higher resting systolic BP and systolic BP reactivity as compared to females (Stoney et
al., 1987). Additionally, it is well-known that college students often exhibit sleeping patterns that
may not be generalizable to the general population, including delayed sleep timing, “night owl”
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tendencies, intentional sleep restriction, and pulling “all-nighters” to complete assignments.
Though participants were requested not to significantly restrict their sleep during the study, it is
recognized that their sleep routines (i.e., bedtimes and wake times) may be more variable than
those of a working individual with a consistent daily routine.
Additionally, the collection of sleep data exclusively on weekdays and not on weekends
is a limitation of the current study, as sleep timing and duration can be highly variable on
weekends or non-working days as compared to weekdays. This variability can be described by
“social jet lag,” or the tendency for individuals to delay their sleep timing on evenings preceding
non-workdays to allow time for socialization and other activities. The term represents a
misalignment between biological and social rhythms on these nights. Students may also tend to
sleep in on non-working days in an effort to compensate for a delayed bedtime or to “catch up”
on missed sleep opportunities during the weekdays (Parsons et al., 2015; Wittmann et al., 2006).
It is thus likely that analyzing three weekdays’ worth of data does not allow for a full picture of
sleep quality on the average over the course of seven days among study participants.
Another important limitation is related to the method of sleep measurement. While an
actigraph watch can provide objective insight into the wearer’s sleep and allows the wearer to
sleep comfortably in their own home (versus in an unfamiliar laboratory), it accounts only for
sleep timing and activity, but not sleep stages. While timing is an important facet of sleep
quality, the duration and proportion of time spent in light sleep, deep sleep, and REM sleep
stages are of equal importance, as different stages are associated with distinct cognitive and
physiological functions (Åkerstedt et al., 2009; Walker, 2009). Though some wearable devices
claim to measure and distinguish between sleep stages, these measures are only approximations
and, unfortunately, the data produced by these devices has not been validated against the gold
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standard of polysomnography (de Zambotti et al., 2019). Thus, the use of such devices for the
purposes of research may not be warranted at this time.
A limitation unique to the time of data collection is that the present study was conducted
during the COVID-19 pandemic. Though it is assumed that any effect of the pandemic on sleep
would be equivalent across participants, it is worth noting the influence of the pandemic on
lifestyle and health behaviors like sleep overall. As stay at home orders and social distancing
measures were enacted, college students across the country found themselves completing
coursework and other activities virtually. This change in routine unfortunately led to disruptions
in sleep patterns like delaying bed and wake times and shifting towards “eveningness” (Genta et
al., 2021). A recent study from Italy found a significant shift in sleep timing as a function of
lockdown and working status, such that students displayed a significant delay in bed timing
during lockdown as compared to before lockdown (Cellini et al., 2021). Some students attended
classes or completed coursework from their beds, therefore interfering with established
associations between the bed and sleep, a known risk factor for insomnia (Perlis et al., 1997). For
this reason, sleep as measured during the pandemic may not be representative of sleep during
pre-pandemic times. Indeed, one study found that in a sample of U.S. young adults, COVIDrelated worry was a significant predictor of poorer sleep quality during the pandemic as
compared to before the pandemic (Hyun et al., 2021). Interestingly, not all studies on sleep
quality during the pandemic indicated negative effects on sleep. One study which examined the
influence of pandemic-related stress on sleep quality in participants of the Netherlands Sleep
Registry found that 20% of self-reported pre-pandemic good sleepers experienced a decrease in
sleep quality during lockdown, while 25% of pre-pandemic participants with insomnia
experienced an increase in sleep quality (Kocevska et al., 2020).
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Another limitation is that this study was done virtually and not in the laboratory. While
completing a stress task from home may approach greater ecological validity, it is possible that
participants did not react as strongly to the stressors at home as they would have in the
laboratory, as they were in a familiar location. However, upon comparison of CVR data from the
current study with data from studies previously conducted in the Behavioral Physiology
Laboratory, no detectable differences were noted. Regardless, it would be worthwhile to examine
other types of stressors that may evoke more reactivity in future research.
Another limitation of this study is that the influence of napping was not considered in
analyses examining the influence of sleep quality on cardiovascular reactivity. While this data
was collected, this was not a primary analysis of interest for the current study.
A final limitation is that due to the remote nature of data collection, we were unable to
collect blood pressure data, as we did not have access to ambulatory blood pressure equipment. It
is also worth noting that this study relied solely on HR and HRV measures, but that other
measures of autonomic functioning might be salient as well (e.g., cortisol). Examining only HR
and HRV parameters may have limited our understanding and viewpoint as to the full patterning
of autonomic nervous system responses to the stressors.
Future Directions
Future studies might consider polysomnography, the gold standard of sleep measurement,
to examine the influence of sleep stage patterning and duration on cardiovascular reactivity to
stress. Additionally, such studies might consider examining behavioral aspects of sleep timing,
such as bed-time variability (described as fluctuations in bedtime and wake times across the
week) and its influence on cardiovascular reactivity to stress. Additionally, the exact direction of
the relation between measures of sleep and CVR is unclear, but it is likely bidirectional, as sleep
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may influence CVR and CVR to stress may influence the quality of one’s sleep. The current
study utilized sleep as a predictor of CVR, however, future studies might consider longitudinal
approaches to examine CVR as a predictor of sleep to clarify the nature of this relation. Finally,
the experimenter effects observed in the current study suggest that participant familiarity with
the experimenter might influence results. As such, it might be useful to ensure that the stress task
experimenter is someone with whom the participants have no prior contact. It would also be
important to consider experimenter demographic factors such as gender, sex, and race as they
compare to the demographic makeup of the participant.
Summary and Implications
The current study was designed to replicate the findings of previous studies in the
literature while controlling for methodological and statistical shortcomings and was adapted to
be conducted in the participants’ natural environments in response to the COVID-19 pandemic.
In addition to the primary interest in clarifying the relation between measures of sleep and CVR,
this study also incorporated measures of self-reported positive and negative affect, as well as task
appraisals, in order to understand how the participants reacted not only physiologically, but
emotionally to the stress tasks. This study found that increased sleep disruption is associated with
a pattern of autonomic nervous system responding consistent with increased sympathetic and
decreased parasympathetic reactivity. Additionally, increased sleep disruption was associated
with increased feelings of stress and decreased persistence during the virtual stress tasks. In
considering the methodology and analyses of future studies involving CVR, these results suggest
that sleep parameters should be considered for control or covariation in future studies of CVR in
addition to variables which are more typically considered, such as substance use, medication use,
etc. Ideally, this could be done via self-report to reduce burden on both the experimenter and the
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participants, as managing the distribution of actiwatches and analyzing the data can be timeconsuming. However, the self-report measure of sleep used in the current study, the PSQI, did
not show significant associations with measures of CVR or recovery from stress. Of note, this
measure assesses quality of sleep over the past month. Perhaps a more efficient method would be
to have participants complete a sleep diary during the course of the study, as this provides a
simple means of collecting recent sleep quality data without the need for technology. Not only do
the results of this study have implications for future methodology, but also for clinical practice. It
is well known that stress is generally linked with adverse health consequences and worse
outcomes across a wide range of diseases (e.g., cardiovascular disease, cancer, diabetes) (Hackett
& Steptoe, 2017; Soung & Kim, 2015; Steptoe & Kivimäki, 2013). When patients undergoing
treatment for these ailments also present with complaints of poor sleep quality or symptoms of
insomnia, it would be wise for providers to also consider the influence of sleep quality not only
on physical health, but on perceived feelings of stress, as sub-optimal sleep may exacerbate the
effects of stress on physical well-being. In general, as CVR to stress is linked with a variety of
health outcomes, the results of this study lend to our understanding of how our sleep may
influence our response to stress and, in turn, our health.
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APPENDIX A: Literature Review of Sleep and Cardiovascular Reactivity
Studies examining the relation between sleep and autonomic response to a stressor have
utilized a variety of tools to measure sleep including more objective measures like
polysomnography and actigraphy, as well as subjective self-report measures of sleep quality. The
literature also includes studies that have examined multiple indices of cardiovascular reactivity
and autonomic functioning across a wide range of stressful stimuli. The findings of these studies
are detailed here.
Normal Sleepers (Habitual Sleep)
A study by Brindle and Conklin (2012) examined the influence of a nap on response to a
mental arithmetic stressor in a sample of 85 healthy undergraduate students. Upon arrival to the
laboratory, participants completed the Pittsburgh Sleep Quality Index (PSQI; (Buysse et al.,
1998) as well as the Karolinska Subjective Sleepiness Scale (KSS; Kaida et al., 2006) and were
randomly assigned to a 60-minute daytime sleep opportunity or to a no sleep opportunity
condition. Sleep state was verified via polysomnography. Cardiovascular reactivity parameters
included MAP and HR. For those in the sleep condition, participants were aroused by
experimenters after 60 minutes had passed, regardless of actual sleep duration (total sleep time)
during that time period. Total sleep time was split into tertiles based on duration (20, 30, and 60
min). Participants in the no-sleep condition completed a serial subtraction stress task
immediately following questionnaire completion, while those in the sleep condition completed
the task no less than one hour after arousal from sleep. Results revealed no significant
differences between sleep and no sleep groups, nor a significant difference between total sleep
time tertile groups for MAP or HR. PSQI global score was also not significantly associated with
MAP or HR for both the sleep and no sleep groups.
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Covassin, De Zambotti, Cellini, Sarlo, and Stegagno (2013) examined the association
between objective (via polysomnography) and self-reported (via global PSQI scores) sleep
quality and CVR in a sample of 26 normotensive (n = 13) and hypotensive (n = 13) females
(mean age 22.3 and 23.1 years, respectively). Study screening criteria included the MorningnessEveningness Questionnaire (MEQ) (Horne & Ostberg, 1976) and those who were deemed
extreme morning or extreme evening chronotypes were excluded from participation. Participants
spent two consecutive evenings in the sleep laboratory, with the first evening being an adaptation
night and the second evening involving the experimental night of polysomnographic sleep
measurement. On the second evening, participants arrived at the laboratory at 8pm and
completed a serial subtraction mental arithmetic stressor for three minutes under speed and
accuracy pressure. After task completion, participants engaged in non-arousing activities prior to
a sleep period from 12am-8am. Results indicated that there were no significant correlations
between PSQI scores and any CVR measure, nor a significant correlation between
polysomnographic measures of total sleep time and task CVR. The authors found that increased
sleep efficiency was significantly associated with decreased sympathetic/enhanced
parasympathetic nervous system response to stress among normotensives and increased wake
after sleep onset was significantly associated with increased sympathetic response to stress. For
hypotensives, the inverse relation was true (i.e., increased sleep efficiency was linked with
increased sympathetic response to stress and increased wake after sleep onset was associated
with decreased sympathetic response to stress). Finally, when considering measures of sleep
architecture (i.e., sleep stage), the results indicated that for normotensives, increases in REM
duration were significantly associated with enhanced parasympathetic reactivity to stress, while
for hypotensives, increased REM duration was linked with increased sympathetic reactivity.
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Williams, Cribbet, Rau, Gunn, and Czajkowski (2013) examined prior month sleep
associations with CVR in a sample of 98 male and female undergraduates. Upon arriving to the
experimental session, participants completed self-report measures of prior month sleep quality
via the PSQI questionnaire as well as prior night (night before the stress task) sleep parameters of
sleep onset latency, total sleep time, and sleep quality. Participants also completed self-report
measures of positive and negative affect. Participants then rank ordered a list of common
stressors and those ranked as most stressful were selected as the topic of a 10-minute acute stress
task which involved re-experiencing the event via verbal description (i.e., the Social Competence
Interview; Ewart et al., 2002). Prior month poor sleep quality and disturbances as measured by
the PSQI significantly predicted dampened DBP reactivity. The authors noted that decreased
prior night total sleep time marginally predicted increased SBP reactivity. They attributed these
seemingly discrepant findings to the differences in sleep parameters involved in each association,
such that DBP was associated with a global self-report measure of sleep quality and SBP was
marginally associated with prior night sleep duration. No significant associations between selfreported prior month or prior night sleep with HR reactivity were found.
Lustyk, Douglas, Shilling, and Woods (2012) examined a sample of 87 women between
the ages of 18 and 45 years old who participated in two 10-minute stress sessions, one during the
follicular and the other during the luteal phase of the menstrual cycle. Participants self-reported
on sleep quality and related parameters via the PSQI questionnaire. During one stress session,
participants completed a cold pressor task, and during a second session they completed the Paced
Auditory Serial Addition Task (Gronwall, 1977). Task/menstrual phase order was
counterbalanced across participants. PSQI measured sleep characteristics did not significantly
predict the typically observed increase in HR or SBP reactivity from the follicular to luteal
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phase. Within cycles, self-reported sleep efficiency was negatively associated with luteal phase
HR reactivity.
Brindle and colleagues (2018) examined the association between total sleep time and
CVR in a sample of 99 males and females (mean age = 59.26 years). Participants completed a
two-night polysomnography sleep study in the laboratory, followed by a stress task protocol in
the morning after the first night (adaptation night). Specifically, participants completed the
multisource interference task with congruent and incongruent stimuli (Bush & Shin, 2006). The
authors chose to dichotomize polysomnography-measured total sleep time and slow wave sleep
percentage into high and low groups using a median split (results were not different when these
variables were treated continuously). Mean total sleep time for the high and low total sleep time
groups was 425.93 (SD = 27.78) and 337.89 (SD = 36.48) minutes, respectively. Just as well,
mean slow wave sleep percentage for the high and low slow wave sleep percentage groups was
16.96 (SD = 6.45) and 3.64 (SD = 2.68) percent, respectively. Results revealed no significant
differences between the high/low total sleep time or high/low slow wave sleep groups on
measures of BP or HR reactivity.
A study by Massar, Liu, Mohammad, and Chee (2017) asked participants to complete
seven consecutive days of at-home wrist actigraphy to assess for habitual sleep parameters of
total sleep time and sleep efficiency. Participants included 59 university student males of
Chinese ethnicity. After one week of actigraphy sleep monitoring, participants arrived at the
laboratory and underwent the Trier Social Stress Test (Kirschbaum et al., 1993) while measures
of HR were measured continuously and BP measurements were taken in one-minute intervals.
The authors discovered that there were no significant associations between total sleep time and
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HR or BP reactivity, nor between sleep efficiency and HR. The authors did find, however, that
sleep efficiency was negatively associated with BP response to the acute stress task.
Mezick, Matthews, Hall, Jennings, and Kamarck (2014) also examined the relation
between sleep parameters and CVR in a sample of 79 undergraduate males (mean age = 19.34
years) who completed one-week of actigraphy. Following actigraphy measurement, participants
completed three acute stress tasks during one scheduled experimental session. The first block of
tasks included the Stroop color-word interference task and the multisource interference task
(presented in counterbalanced order across participants). All participants then completed an oral
defense speech task (defending oneself against a traffic violation in front of a camera) during the
second block. From a series of linear regressions controlling for total sleep time, age, race, BMI,
habitual caffeine/nicotine use, task appraisals, and nap times, results indicated that total sleep
time was positively associated with HF-HRV, only during the Stroop and multisource
interference task. Authors also analyzed sleep the night before the laboratory protocol and found
no significant associations between prior night total sleep time and any CVR measure.
A study by Palesh et al. (2008) examined the association between sleep and respiratory
sinus arrhythmia (RSA) in a sample of 99 women with breast cancer, aged 54.6 years.
Participants engaged in three nights of actigraphy monitoring and then underwent the Trier
Social Stress Test (Kirschbaum et al., 1993) during a scheduled laboratory session. RSA
reactivity to the stress task was significantly positively related to sleep efficiency, and negatively
related to number of wake events, wake after sleep onset and wake event length. In addition,
sleep efficiency, wake after sleep onset, number and length of wake events were best predicted
by RSA reactivity. No significant associations were found between time in bed or sleep onset
latency and RSA reactivity.
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Normal Sleepers (Sleep Restriction and Deprivation)
A study by Zhong et al. (2005) examined the effects of acute sleep deprivation on CVR
during cognitive tasks. Eighteen participants (mean age = 26.0 years) arrived to the sleep lab at
5pm on day one of the study and remained until 9am of day three, and were continuously
monitored for signs of sleep onset. During this period, participants remained in the laboratory in
their assigned bedroom or in the common room. When not involved in testing or tasks,
participants were allowed to engage in activities such as school or job-related work, watching
movies, or interacting with staff and visitors. Physiological measurements to several cognitive
tasks (reaction time task, shape go/no go task, and 2-back task) were obtained at four time points,
at baseline (9pm on first night of study), 9am and 9pm of the second day, and 7am the third day.
Authors concluded that across the three cognitive stress tasks, sleep deprivation at 12, 24, and 36
h were each significantly associated with increased sympathetic and decreased parasympathetic
cardiovascular reactivity to the stress tasks as compared to baseline. A significant positive
association between number of hours of sleep deprivation and HR reactivity was only found
during the shape go/no go task.
James and Gregg (2004) studied a sample of 96 university students who were habitual
caffeine consumers (mean age = 19 years) who completed a four-week protocol in which they
ingested either a caffeine or placebo pill for two weeks each. At the end of each of week,
participants engaged in two laboratory stressors after a night of usual sleep or a night of sleep
restriction. Self-reported sleep diary measures of habitual sleep were used to determine habitual
sleep, and sleep was restricted to 60% of habitual sleep time. Adherence to the sleep restriction
protocol was confirmed via wrist actigraphy. Participants thus completed four stress task
sessions and arrived to the laboratory under one of four conditions each time, including usual
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sleep/placebo, usual sleep/caffeine, restricted sleep/placebo, and restricted sleep/caffeine. Stress
tasks included a sustained vigilance task and a six-test cognitive battery. HR and cardiac output
reactivity to stress tasks were decreased and total peripheral resistance reactivity was increased
after sleep restriction compared to rest. Additionally, cardiac output reactivity was lower after
the restriction/caffeine condition as compared to the restricted/placebo, or rested/caffeine or
placebo conditions.
In a study by Franzen et al. (2011), 20 participants (mean age = 23.25 years) completed
two conditions; a night of normal sleep in the laboratory (rested wakefulness) and a night of total
sleep deprivation, separated by one week and confirmed via polysomnography. Conditions were
completed in counterbalanced order across participants. During each of the two sessions,
participants completed an adaptation night followed by an experimental night of sleep, and
completed stress tasks in the morning following the experimental night. Participants completed a
Stroop color-word naming interference task, as well as a speech preparation and delivery task
while measures of HR and BP were recorded. Results revealed that SBP reactivity to mental
stress was higher in the total sleep deprivation group compared to the normal sleep group during
the speech task only.
A study by O’Leary, Howard, Hughes, and James (2013) examined CVR to a stressor in
70 Type D and non-type D undergraduate females (mean age = 18.41 years). Individuals
considered as Type D exhibit distress and strong negative affectivity, as well as social inhibition
(Denollet et al., 1996). Participants either engaged in a night of usual sleep or restricted sleep the
night prior to a stress protocol (and confirmed via actigraphy). Sleep restriction was defined as
sleeping 40% of the participant’s habitual sleep time (as measured by a one-week sleep diary).
On the morning after sleep restriction or usual sleep, participants reported to the laboratory to
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complete a mental arithmetic task while observed by a confederate who provided negative
feedback. Results revealed no significant direct association between sleep and CVR measures of
BP and HR. An indirect association was revealed for non-Type D individuals only, such that
sleep restricted women exhibited significantly lower SBP reactivity than rested women.
Yang, Durocher, Larson, DellaValla, and Carter (2012) examined the association
between sleep deprivation and CVR to acute stress in a sample of 28 participants (mean age = 22
years). Participants completed both a night of normal sleep and a night of total sleep deprivation
(confirmed via actigraphy for three consecutive nights), separated by one month and followed by
a stress protocol the next day each time. Order of the sleep versus deprivation trials was
randomized across participants. The stress protocol included both a serial subtraction task as well
as the cold pressor test. After total sleep deprivation, HR reactivity was significantly greater in
both the mental arithmetic and cold pressor task as compared to after a night of normal sleep.
A study by Kato et al. (2000) examined the association between sleep deprivation and
CVR in a sample of eight participants with a mean age of 40 years. Participants spent two nights
in the laboratory, engaging once in a night of normal sleep and once in a night of total sleep
deprivation, in randomized order and separated by at least four days. No objective or selfreported sleep measures were used to confirm adherence; however, the authors noted that the
nurses ensured sleep versus awake status via a behavioral check. After each of the two nights
spent in the laboratory, participants engaged in four stressor tasks the following morning,
including mental arithmetic, hand grip, maximal forearm ischemic response, and the cold pressor
task. Results revealed no significant differences between rested versus deprived conditions for
BP or HR reactivity during any of the four stress tasks.
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A study by Muenter et al. (2000) hypothesized that CVR response to orthostatic stress
and lower body negative pressure in an airtight chamber would be attenuated by sleep restriction.
Participants included 10 men and women ranging in age from 22-46 years. Participants
completed baseline polysomnography monitoring night followed by a baseline cardiovascular
lower body negative pressure test, four consecutive nights of sleep restriction (four hours/night),
and a post-sleep restriction cardiovascular test. The lower body negative pressure test was a
measure of orthostatic tolerance and required the participant to stand in an airtight chamber that
gradually increased to -60 mmHg of pressure. Results indicated differences in CVR to lower
body negative pressure such that after sleep restriction, SBP was significantly higher during the
first three minutes spent at -60 mmHg, and HR was significantly decreased during the last 30
seconds of lower body negative pressure, as compared to before sleep restriction (baseline). No
significant effect of sleep restriction was found during orthostasis.
Insomniacs Versus Good Sleepers
A study by Chen, Jarrin, Ivers, and Morin (2017) examined physiological responses to
the Trier Social Stress Test (Kirschbaum et al., 1993) in a sample of 30 young adults with a mean
age of 26.7 years. Participants underwent a semi-structured interview (i.e., the Insomnia
Interview Schedule (Morin, 1993) and completed the Ford Insomnia Response to Stress Test
(FIRST) (Drake et al., 2004) and the Insomnia Severity Index (ISI) (Morin et al. 2011). The
FIRST is used to assess one’s vulnerability to developing sleep problems as a result of stressful
situations, and the ISI is intended to assess the nature, severity, and impact of insomnia
symptoms over the past month. Participants were then placed into one of three groups according
to pre-specified criteria; (1) insomnia (n = 10; based on DSM-V and ICD-10 diagnostic criteria,
an ISI score of ≥ 10, and an ISI distress item score of ≥ 2, indicating clinically significant
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distress and daytime dysfunction), (2) good sleepers with high insomnia vulnerability (n = 10;
FIRST score ≥ 20), and (3) good sleepers with low insomnia vulnerability (n = 10, FIRST score
≤ 19). Participants underwent two nights of polysomnography recording in a sleep laboratory,
and the Trier Social Stress Test (Kirschbaum et al., 1993) was completed prior to bedtime on the
second night. Results revealed that BP reactivity was significantly negatively correlated with
mean total sleep time (as measured via polysomnography) across participant groups. In addition,
results indicated that the LF/HF ratio reactivity was positively associated with wake after sleep
onset, and that SBP and DBP reactivity were both positively correlated with sleep onset latency,
and negatively correlated with sleep efficiency. No significant differences were found between
high and low vulnerability and insomnia groups for any CVR measure (i.e., HR, HRV, or BP).
A study by Castro-Diehl et al. (2016) examined the association between total sleep time,
sleep efficiency, and CVR to several stressors in a sample of 527 middle aged and older adults
(age range 45-84 years). Participants completed a sleep protocol which included one week of athome actigraphy to assess for habitual total sleep time, and one night of at home
polysomnography to assess for apnea hypopnea index. Both male and female participants also
filled out the Women’s Health Initiative Insomnia Rating Scale, and a score of ≥ 9 indicated
clinically significant insomnia (Levine et al., 2005). After the seven-day sleep assessment,
participants arrived at the laboratory and completed two, six-minute mental stress tasks
(including a mental arithmetic and Stroop color-word interference task, in counterbalanced
order) as well as an orthostatic stressor in which they held a standing position for six minutes.
Compared to those who slept 7 to 8.9 hours/night, those who slept < 6 hours had significantly
higher HR during mental and orthostatic stress, and those who slept < 7 hours had greater HR
during both stressors compared to those sleeping 7 hours or more. In addition, those who slept <
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7 hours a night and who also had insomnia had greater HR during orthostatic stress, and greater
HF-HRV during mental stress, compared to those who slept ≥ 7 hours without insomnia. The
authors noted that the increase in sympathetic tone during the physical stressor as compared to
the increase in parasympathetic tone during the mental stressor may have resulted because,
overall, participants in the study did not react strongly to the mental stressor. The authors also
categorized participants into high (SE% ≥ 85%) and low (SE% < 85) sleep efficiency groups;
however, no significant results were obtained for CVR between sleep efficiency groups.
Cellini, de Zambotti, Covassin, Sarlo, and Stegagno (2014) examined CVR differences
between primary insomniacs (n = 13) and good sleepers (n = 13) with a mean age 23.81 years.
Participants completed the PSQI and the ISI and were classified as primary insomniacs if they
scored ≥ 5 on the PSQI or ≥ 11 on the ISI. Additionally, primary insomniacs had to report
insomnia symptoms of at least six months in duration and satisfy the Research Diagnostic
Criteria for Primary Insomnia (Edinger et al., 2004). Participants were classified as good sleepers
if they scored below these cut-off scores on each questionnaire and if they satisfied the Research
Diagnostic Criteria for Normal Sleepers (Edinger et al., 2004). All participants underwent a twonight polysomnography recording to confirm these sleep groupings. The study protocol required
participants to undergo two cognitive tasks on the laboratory sleep adaptation evening, including
an easy letter memory task and an N-back task. Results indicated that for the easy task, primary
insomniacs had shorter pre-ejection period response (i.e., greater sympathetic response) relative
to good sleepers. For the difficult task, only good sleepers showed significant decreases in HFHRV (i.e., reduction in parasympathetic influence) between the baseline and task period, while
no change was observed for primary insomniacs between these periods.
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A study by Stepanski, Glinn, Zorick, Roehrs, and Roth (1994) examined a sample of 49
males with chronic insomnia (less than 85% sleep efficiency) or normal sleep (90% sleep
efficiency). Mean age for the insomnia group was 34.5 years and mean age for the normal
sleeper group was 34.0 years. Participants were considered to have insomnia if they self-reported
disturbed sleep at least five nights during the week for at least six months, and if they met the
American Sleep Disorders Association criteria for psychophysiological or idiopathic insomnia
(Sleep Disorders Classification Committee & Roffwarg HP, 1979). Participants completed an
initial eight-hour overnight polysomnography measurement to confirm placement in the
insomnia versus normal sleeper group, as well as to serve as a laboratory sleep adaptation night.
Normal sleepers were required to have a sleep efficiency of greater than 90%, and those with
insomnia were required to have less than 85% sleep efficiency. The following week, participants
completed the experimental polysomnography night. Upon waking the following morning,
participants engaged in a stress task that required them to discriminate a target tone from other
tones while under time pressure. Analyses revealed that chronic insomniacs had a higher HR
response to this task as compared to normal sleepers, indicating that poorer sleep quality was
related to increased autonomic reactivity.
Covassin et al. (2011) explored whether CVR differences existed between insomniacs (n
= 8) and good sleepers (n = 8). Mean participant age was 22.9 years and 24.8 years for
insomniacs and good sleepers, respectively. Participants were classified as being in the insomnia
group if they met DSM-IV criteria for primary insomnia symptoms for at least one year prior to
the study, as well as had a PSQI score of ≥ 6, ISI score of ≥ 11, and an Athens Insomnia Scale
score of ≥ 6 (Soldatos et al., 2000). Good sleepers were required to fall below the
aforementioned cut-off scores and to deny any major sleep complaints. One week of wrist
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actigraphy and two nights of polysomnography sleep measurement were utilized to exclude
circadian disorders and to confirm insomnia versus good sleep groupings. Participants arrived to
the laboratory for a polysomnography adaptation evening, and then completed the Stop-Signal
Task (Logan & Cowan, 1984; Logan et al., 1984) during the second evening and again in the
morning after waking. Completing the task during the evening and again in the morning allowed
researchers to statistically account for time of day effects on hyperarousal in insomniacs (Bastien
et al. 2008). Results revealed that HR response to stress was higher and left ventricular ejection
time reaction was lower in insomniacs compared to good sleepers in the evening session. Preejection period response was significantly lower in insomniacs (i.e., increased sympathetic
response) compared to good sleepers across both evening and morning sessions. In addition, for
the good sleeper control group only, HR reactivity to stress was significantly higher in the
morning as compared to evening.
Haynes, Adams, and Franzen (1981) compared insomniacs (n = 11) and normal (n = 11)
sleepers (age range of 18-21 years) on measures of HR response to mental stress. Individuals
were classified as insomniacs or normal sleepers based on a diagnostic interview. To be
classified into the insomnia group, participants had to report sleep problems for greater than two
years, have an average sleep onset latency of greater than 60 minutes (confirmed via
polysomnography), and issues with sleep onset greater than four times per week. Those
classified as normal sleepers were required to report no significant history of sleep difficulties,
average sleep onset latency of 10 minutes, and rare issues with falling asleep. Participants
completed five consecutive nights of laboratory polysomnography and were asked to complete a
seven minute and thirty second serial subtraction mental arithmetic task under time pressure for
two consecutive nights (nights four and five) before sleep onset. The authors found no significant
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difference in HR reactivity between normal sleepers and those with insomnia during the stress
task.
Schmidt, Richter, Gendolla, and Van Der Linden (2010) examined differences in HR and
MAP reactivity to a memory stressor in a predominantly female sample of 77 university students
of mean age 22.2 years. Participants arrived at the laboratory and for a 30-minute experimental
session that required them to complete a memory task with immediate and delayed recall while
measures of HR and BP were recorded. Participants also completed several questionnaires to
assess their sleep quality including the ISI, the Multidimensional Fatigue Inventory (MFI)
(Gentile et al., 2003; Smets et al., 1995) and a questionnaire developed by the authors titled the
Actual Sleep and Fatigue Questionnaire (ASFQ), which asked patients to evaluate sleep quantity
and quality the night before the experiment on a 10-point Likert type scale. Results indicated that
ISI scores of insomnia severity were significantly positively correlated with both SBP and MAP
reactivity to stress. When ISI scores were analyzed based on cut off scores for differences
between no insomnia (ISI = 0-7), subthreshold (ISI = 8-14), or moderate to severe clinical (ISI =
15-28) insomnia groups, results indicated a significant linear trend such that insomnia severity
grouping (or increases in level of insomnia severity) was positively associated with SBP
reactivity to stress. This was also true when the ISI score was analyzed continuously to predict
SBP response to stress. No significant associations between sleep and CVR were found when
scores on the MFI or the ASFQ were utilized in analyses.
A study by Young (2011) recruited a sample of 38 participants with non-REM
parasomnias (n = 11, mean age = 26.18 years), insomnia (n = 12, mean age = 48.25 years), and
good sleep (n = 15, mean age = 37.53 years. Those with non-REM parasomnias had to meet the
International Classification of Sleep Disorders, Second Edition (ICSD-2; AASM, 2005) criteria
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for sleepwalking or sleep terrors, and those with insomnia were required to meet ICSD-2 general
criteria for insomnia. Good sleepers were those who reported no current sleep difficulties and
reported that they were satisfied with their current amount of sleep. Participants reported to the
laboratory to engage in a mental arithmetic stressor under accuracy and time pressure. Results
indicated that for both HR and cardiac vagal measures, there were no significant differences
between the three groups in CVR.
Carter et al. (2018) assessed 24 individuals with chronic insomnia (n = 12) or normal
sleep (n = 12) during the cold pressor test. Mean age for the insomnia participants was 37 years
and for the controls was 41 years. Those with insomnia were required to meet DSM-V criteria
for persistent insomnia disorder, have an ISI score of greater than 14, a PSQI score of greater
than 5, and a habitual sleep time of less than six hours and 30 minutes a night. Normal sleepers
were required to have an ISI score ≤ 7, PSQI score of ≤ 5, and a habitual sleep time of greater
than 6.5 and less than 9 hours. One night of polysomnography was implemented to screen for
sleep apnea, and then two weeks of actigraphy monitoring was completed to assess for habitual
sleep duration and quality, and to confirm group assignment. Participants then returned to the
sleep laboratory for a night of sleep with wrist actigraphy monitoring. In the morning,
participants completed a two-minute cold pressor test. Interestingly, the authors found no
significant differences in polysomnography-measured sleep between the two groups, but
experimental actigraphy night data revealed significantly lower total sleep time and sleep
efficiency, and higher wake after sleep onset in the insomnia group compared to controls. After
controlling for participant age, BMI, sex, and race, results revealed that SBP reactivity was
elevated in the insomnia group as compared to the normal group during the cold pressor task.
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Demographic Questionnaire

Height (in.):_________

Weight (lbs.):_________

Please provide your email address so that we can contact you for part 2 of the study:
_______________________________________
Your Information:
Age _______yrs.
What is your gender identity?
o Female
o Male
o Transgender
o Nonbinary/fluid queer/gender queer
o Not listed (please specify if you choose): ___________
o I prefer not to answer
Yes, another Hispanic, Latino Are you Hispanic, Latino, or of Spanish origin?
o No, not of Hispanic, Latino, or Spanish origin
o Yes, Mexican, Mexican American, Chicano
o Yes, Puerto Rican
o Yes, Cuban
o Yes, another Hispanic, Latino, or Spanish origin (please indicate) ____________
Race- check all that apply
○ White
○ Black or African American
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○ American Indian or Alaska Native
○

Asian

○

Native Hawaiian or Other Pacific Islander

o Other (please indicate) _______________
What is the highest level of education you have completed to date?
○ High school
○ 1 year of college
○ 2 years of college
○ 3 years of college
○ 4 or more years of college
What is your intended major (s) at WVU? _______________________________
Please describe any cardiovascular related illness that you may have, including high blood
pressure (if none, please write “N/A”):
_________________________________________________________
Have you ever been diagnosed with a sleep-related disorder such as insomnia, narcolepsy,
obstructive sleep apnea, parasomnia, etc.? If yes, please
describe_______________________________________________________
Please list any other medical, psychiatric, or mental health problems that you have:
________________________________________
Please list any major surgeries and medical, or psychiatric illnesses you have had in the past
year: _________________________________________________
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Females: Are you currently pregnant?
○ Yes
○ No
Females: Are you currently on birth control (contraceptives).
○ Yes
○ No
What type of birth control are you taking? ________________________
Please list any drugs (legal or otherwise) that you are currently taking including; birth control
(contraceptives), heart medications, cold or allergy medications, over the counter medications,
asthma medications, Beta-Blockers (i.e. Inderal, Tenormin), psychoactive drugs (i.e. Adderall,
Xanax, Haldol, Lithium, Prozac), or diet pills: ______________________________________
Have you used tobacco products in the last month?
○ Yes
○ No
If yes, which tobacco products have you used? (Select all that apply)
○ Cigarettes
○ Electronic/e-cigarettes
○ Smokeless tobacco/chew
○ Vape (with nicotine)
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How often do you drink alcohol?
○ Never
○ Infrequently (a few drinks per year)
○ Occasionally (1-2 drinks per month)
○ Weekly (1-3 drinks per week)
○ Weekly (3-6 drinks per week)
○ Daily (1-2 drinks per day)
○ Daily (more than 2 drinks per day)
How many cups of caffeinated coffee, tea, soda, or energy drinks (e.g. Red Bull, 5-hr Energy)
do you have on a typical day?
○ None
○ 1-2 cups per day
○ 3-4 cups per day
○ 5-6 cups per day
○ 7-8 cups per day
○ Greater than eight cups per day
How many times per week do you engage in aerobic physical activity?
○ Never
○ 1-2 times
○ 3-6 times
○ 7 or more times
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For how long do you typically exercise on each occasion?
○ 5-10 minutes
○ 11-15 minutes
○ 16-30 minutes
○ 31-60 minutes
○ More than 60 minutes
Family Information:
Imagine a ladder that represents where people stand in the United States. At the top of the ladder
are the people who are the best off – those who have the most money, the most education, and
the most respected jobs. At the bottom are the people who are the worst off – who have the least
money, least education, and the least respected jobs or no job. The higher up you are on this
ladder, the closer you are to the people at the very top; the lower you are, the closer you are to
the people at the very bottom.
On which rung of the ladder (1 being the lowest rung and 10 being the highest rung)
would you place your family?
1……….2……….3……….4……….5……….6……….7……….8……….9……….10
Is your father currently living?
○ yes
○ no
Approximately how old is your father? _________
Did/does your father have high blood pressure (hypertension)?
○ yes
○ no
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How certain are you that he did, or did not, have high blood pressure (hypertension)?
○ Absolutely (100%) certain
○ Almost (75%) certain
○ Not sure at all (25%)
○ No information by which to judge (0%)
Did/does your father have any heart problems such as angina (chest pains), a heart attack, or
coronary heart disease?
○ yes
○ no
If yes, please specify if you are able: ______________________________________________.
How certain are you that he did, or did not, have a heart problem as indicated above?
○ Absolutely (100%) certain
○ Almost (75%) certain
○ Not sure at all (25%)
○ No information by which to judge (0%)
Is your mother currently living?
○ Yes
○ No
Approximately how old is your mother? _________
Did/does your mother have high blood pressure (hypertension)?
○ Yes
○ No
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How certain are you that she did, or did not, have high blood pressure (hypertension)?
○ Absolutely (100%) certain
○ Almost (75%) certain
○ Not sure at all (25%)
○ No information by which to judge (0%)
Did/does your mother have any heart problems such as angina (chest pains), a heart attack, or
coronary heart disease?
○ Yes
○ No
If yes, please specify which problem(s) (if unsure, write “Unsure”):
______________________________________________.
How certain are you that she did, or did not, have a heart problem as indicated above?
○ Absolutely (100%) certain
○ Almost (75%) certain
○ Not sure at all (25%)
○ No information by which to judge (0%)
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Sleep Diary

Day
and Date

Sample:
Mon 9/14

Fatigue
rating

70

Nap
Start &
end times

2 – 4 pm

Fatigue
Rating
Scale

Sleep
meds or
alcohol
Name &
dose

Ambien
10 mg

0
Extremely
fatigued

Time
you
went to
bed and
turned
out
lights

How
long it
took to
fall
asleep
for the
first time

(A)

(B)

12:00

40 min

25
Moderately
fatigued

Number
of times
you
woke up
after
falling
asleep

3

50
Mildly
fatigued

How
long you
were
awake
during
the night

Time
you
woke up
this
morning
for the
last time

Desired
wake
time

(C)

(D)

(E)

60 min

7:00

8:00

75
Somewhat
energetic

100
Very
energetic
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Daily Habits Questionnaire
Physical Activity
1. During the last 24 hours, did you do vigorous physical activities like heavy lifting, digging,
aerobics, or fast bicycling? Vigorous physical activities refer to activities that take hard
physical effort and make you breathe much harder than normal. Think only about those
physical activities that you did for at least 10 minutes at a time.
o Yes
o No
2. If yes, how much time did you spend doing vigorous physical activities?
o _____ hours
o _____ minutes
o Don’t know/Not sure
3. During the last 24 hours, did you do moderate physical activities like carrying light loads,
bicycling at a regular pace, or doubles tennis? Moderate activities refer to activities that take
moderate physical effort and make you breathe somewhat harder than normal. Think only about
those physical activities that you did for at least 10 minutes at a time. Do not include walking.
o Yes
o No
4. If yes, how much time did you spend doing moderate physical activities?
o _____ hours
o _____ minutes
o Don’t know/Not sure
5. During the last 24 hours, did you walk for at least 10 minutes at a time? This includes at work
and at home, walking to travel from place to place, and any other walking that you have done
solely for recreation, sport, exercise, or leisure.
o Yes
o No
6. If yes, how much time did you spend walking?
o _____ hours
o _____ minutes
o Don’t know/Not sure
7. The last question is about the time you spent sitting during the last 24 hours. Include time
spent at work, at home, while doing course work and during leisure time. This may include time
spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch television.
During the last 24 hours, how much time did you spend sitting?
o _____ hours per day
o _____ minutes per day
o Don’t know/Not sure
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Alcohol/Caffeine
1. In the last 24 hours, did you consume any alcoholic beverages?
a. Yes
b. No
2. If yes, how many alcoholic beverages did you consume? Remember that a standard drink
is a 1.5 ounce shot of liquor, 12 ounces of beer, or 5 ounces of wine.
a. ___________ (# of drinks)
3. If yes, at approximately what time of day did you consume alcohol? (select all that apply)
a. Morning
b. Afternoon
c. Evening
4. In the last 24 hours, did you consume caffeine in any form?
a. Yes, caffeine pills
b. Yes, coffee
c. Yes, energy drinks
d. No
5. If yes, how many milligrams of caffeine pills did you take? _____ # milligrams
6. If yes, how many ounces of coffee did you consume? _________ # ounces
7. If yes, how many energy drinks did you consume? (One “Monster energy drink” is
equivalent to 16 fl. oz) _______ # drinks

8. If yes, at approximately what time of day did you consume caffeine? (select all that
apply)
a. Morning
b. Afternoon
c. Evening

Daily Stress Rating
1. Circle the number that best describes how the past day (24 hours) has been for you in
terms of feelings of stress.

No Stress
0
1

2

3

4

5

6

7

8

Most stress
9
10
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Post Task Questionnaire
Instructions:
For each of the statements located below, please circle one of the scale categories
to the right of each statement. Use the scale as shown below:
Very Low

Somewhat Low

Neutral

Somewhat High

Very High

1

2

3

4

5

1. How stressful was the task?.…………………..………………………………..1

2

3

4

5

2. How difficult were the problems on this task? ...................................................1

2

3

4

5

3. How hard did you try to complete the problems?................................................1

2

3

4

5

4. How well do you think you performed on the task?..............................………..1

2

3

4

5

5. How persistent were you in completing the task? ……………………….... 1

2

3

4

6. How upset are you by your performance on the task?.........................................1

2

3

4

5
5
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APPENDIX C: PRELIMINARY ANALYSES
For information on mean, standard deviation, range, minimum, and maximum values for
primary study predictor and outcome variables, please see Table C.1.
Testing for Assumptions of Multiple Linear Regression
All continuous variables were inspected for violations of univariate normality. Twentyseven variables were skewed and subsequently log transformed. Negatively skewed variables
were reflected before and after log transformation for ease of interpretation.
Next, data was inspected for violations of the assumptions of multiple linear regression.
A scatterplot revealed a linear relationship between three-day average sleep predictor variables
and reactivity outcome variables, as well as prior night sleep predictor variables and reactivity
outcome variables. Collinearity diagnostics were run to test for multicollinearity. Data were
considered to be free of multicollinearity if tolerance was greater than 0.20 and VIF was less
than 4.0. For three-day average TST and SE, tolerance was 0.83 and VIF was 1.21. For prior
night TST and SE, tolerance was 0.84 and VIF was 1.19. In addition, a bivariate correlation
matrix was created to determine whether predictor variables might be too highly correlated
(defined as r ≥ 0.80), and correlation coefficients were deemed within the appropriate range. For
three-day average TST and SE, r = .42, p < .01, and for prior night TST and SE, r = .40, p < .01.
Assumptions of homoscedasticity were checked via visual inspection of the scatterplot of the
residuals and data was confirmed to be homoscedastic.
Demographic Variables: SONA and Laboratory Sample
Due to substantial differences in SONA and laboratory sample size, statistical analyses to
compare the two groups were not conducted. The groups were, however, visually compared on
all measured demographic variables (See Table C.2). Overall, both the SONA and laboratory
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samples were similar as they both consisted of young, single, Caucasian individuals who
identified as women with a heterosexual orientation.
Self-Report Sleep Variables: Lab Sample
Prior to the laboratory protocol, participants completed the PSQI, MEQ, and KSS
questionnaires, which are self-report measures of sleep quality, chronotype, and sleepiness. For
the PSQI, the mean score across participants was M = 7.12, SD = 4.17, with a range from 0-16.
Scores of greater than 5 on the PSQI indicate clinically significant sleep disturbance in greater
than or equal to two areas (e.g., sleep onset latency, middle of the night awakenings, etc.). For
the MEQ, the mean score across participants was M = 48.90, SD = 7.04, with a range from 3161. Scores from 31-41 indicate moderate eveningness, scores from 42-58 indicate intermediate
chronotype, and scores from 59-69 indicate moderate morningness. Results confirmed that the
laboratory sample did not fall into the < 31 (definite eveningness) or > 70 (definite morningness)
categories. For the KSS, the average score was M = 3.66, SD = 1.56, which indicated that on
average participants felt alert to rather alert just prior to completing the virtual stress protocol.
Consideration of Covariates
Pearson correlations were calculated between measures of sleep and CVR with potential
covariates (BMI, MEQ, PSQI, and KSS) to determine whether any needed to be added into the
primary regression analyses (See results in Table C.3). Results revealed no significant
associations between any of these potential covariates and measures of sleep or CVR and
consequently were not entered into the primary regression analyses.
Preliminary Analyses: Cardiovascular Parameters
Baseline and Rest/Recovery Periods. To determine whether there were significant
minute to minute differences in HR across the five-minute baseline and rest/recovery periods,
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one-way repeated measures ANOVAs were conducted, followed by post-hoc comparisons using
Tukey’s test. HRV measures were not subjected to these analyses, as measures of HRV are
unreliable across one-minute intervals. Conducting one-way repeated measures ANOVAs with a
Greenhouse-Geisser correction revealed significant main effects for minute-to-minute
differences during the baseline period, F(3.02, 148.16) = 4.45, p < .01, ηp2 = .08, and the first rest
period, F(2.93, 143.78) = 2.91 p < .05, ηp2 = .06, but not the final recovery period, F(3.01,
147.62) = 1.03, p =.38, ηp2 = .02.
Pairwise comparisons using Tukey’s test revealed a significant difference between mean
HR at minute one (M = 76.8 bpm, SD = 1.30) and minute five (M = 78.52 bpm, SD = 1.40) at the
p < 0.05 level during the baseline period. For the first rest/recovery period, minutes two (M =
77.0 bpm, SD = 9.66) and five (M = 78.7 bpm, SD = 9.82) were significantly different at the p <
.01 level. These results suggested an anticipation effect, such that participants’ HR increased
from earlier minutes to minute five as they expected starting the stress task. To remove this
anticipatory effect, a second pair of one-way repeated measures ANOVAs with GreenhouseGeisser corrections was conducted utilizing only minutes one through four for both baseline and
the first rest periods. No significant main effect was observed for the first rest/recovery period,
F(2.14, 104.94) = 1.78, p = .17, ηp2 = .04. However, for baseline, a significant main effect was
still observed, F(2.55, 124.70) = 3.99, p < .05, ηp2 = .08, and pairwise comparisons showed a
significant difference between minute one (M = 76.8 bpm, SD = 9.19) and minute four (M = 78.2
bpm, SD = 9.50). A third one-way repeated measures ANOVA utilizing only baseline minutes
one through three resulted in no significant main effect for the baseline, F(1.57, 77.06) = 3.05, p
= .07, ηp2 = .06, and the rest period in between tasks, F(1.60, 78.49) = 1.52, p = .23, ηp2 = .03.
Thus, minutes one, two and three were averaged to create mean baseline and rest/recovery period
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HR values, excluding minutes four and five. This decision resulted in equivalent 3-min durations
for each baseline, rest/recovery, and task periods which has the benefit of addressing any
argument that differing durations of task and rest/recovery periods would influence HRV
determination.
Recovery Period. While considering recovery analyses, it was recognized that a time
span of approximately one minute elapsed between the completion of the stress task and the
beginning of the recovery period, and that utilizing the first minute of the recovery period to
mark the commencement of recovery would not account for any change in HR that occurred
between the last minute of the task and first minute of recovery. Thus, it was decided that
the last minute of heart rate data from each task period would be considered as minute one of
recovery, followed by minutes one and two of the measured recovery period for a total of three
minutes. AUC were calculated for HR during this 3-min recovery period.
Reactivity to the Two Virtual Tasks. To examine whether participants displayed
increased autonomic reactivity during the stress tasks, a 2 (Task Type: Math, Raven) x 2 (Period:
Baseline, Task) repeated measures ANOVA was conducted for measures of HR, HRV, and
respiration (See ANOVA Summary Tables C.4-C.8). For HR, there was a significant main effect
of Task Type, as HR was greater during the mental arithmetic task (M = 80.8 bpm, SE = 1.2), as
compared to the Raven’s matrices task (M = 78.6 bpm, SE = 1.3). There was also a significant
effect for Period, as HR was greater during the task periods (M = 82.0 bpm, SE = 1.3), as
compared to the pre-task rest periods (M = 77.4 bpm, SE = 1.3). In addition, a significant
interaction was observed between Task Type and Period, such that HR was the highest during
the math task (M = 84.1 bpm, SE = 1.31) followed by the Raven’s matrices task, (M = 80.0 bpm,
SE = 1.4), the pre-math rest period, (M = 77.6 bpm, SE = 1.3), and the pre-Raven rest period, (M
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= 77.2 bpm, SE = 1.4). Analysis of simple effects with a Tukey’s test revealed a significant
difference between HR during the mental arithmetic and Raven’s matrices task periods (p < .05),
but no difference between HRs observed during the pre-task rest periods.
For RMSSD, there was no significant main effect of Task Type; however, there was a
significant main effect of Period, such that RMSSD was higher during the pre-task rest periods
(M = 1.59 log ms, SE = 0.03) as compared to during the task periods (M = 1.53 log ms, SE =
0.03). There was also a significant interaction between Task Type and Period, such that RMSSD
was the highest during the pre-math task rest period (M = 1.60 log ms, SE = 0.03) followed by
the pre-Raven rest period, (M = 1.58 log ms, SE = 0.04), the Raven task period, (M = 1.56 log
ms, SE = 0.03), and the mental arithmetic task period, (M = 1.50 log ms, SE = 0.03). Analysis of
simple effects with a Tukey’s test revealed a significant difference between RMSSD during the
mental arithmetic and Raven’s matrices task periods (p < .05) but no difference between RMSSD
observed during the pre-task rest periods.
For LF-HRV, there was no significant main effect and no significant interactions. For
HF-HRV, there was no significant main effect of Task Type, however, there was a significant
main effect of Period such that HF-HRV was higher during the pre-task rest periods (M = 6.43
log ms2, SE = .17) as compared to during the task periods (M = 6.16 log ms2, SE = .15). There
was no significant interaction between Task Type and Task Period.
For respiration rate, there was no significant main effect of Task Type, but there was a
significant main effect of Period, such that respiration rate was higher during the task periods (M
= 0.26 Hz, SE = .01) as compared to the pre-task rest periods (M = 0.24 Hz, SE = .01). There was
also a significant interaction between Task Type and Period, such that respiration rate was the
highest during the Raven task period (M = 0.27 Hz, SE = .01) followed by the mental arithmetic
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task period, (M = 0.25 Hz, SE = .01), the pre-math rest period, (M = 0.24 Hz, SE = .01), and the
pre-Raven rest period, (M = 0.24 Hz, SE = .01). Analysis of simple effects with a Tukey’s test
revealed a significant difference between respiration rates during the mental arithmetic and
Raven’s matrices task periods (p < .05) but no difference between respiration rates observed
during the pre-task rest periods.
In sum, these results confirm that the participants responded to the stress tasks as
anticipated, with a patterning of cardiovascular reactivity to mental stress that reflected increased
sympathetic nervous system activity and decreased parasympathetic nervous system activity.
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Table C.1. Descriptive Statistics for Primary Predictor and Outcome Variables
N
Range Minimum
Maximum
Mean
3Avg TST (min)
50 277.83
236.67
514.50
397.52
3Avg #Wake Bouts
50
59.67
18.00
77.67
44.02
3Avg WASO (min)
50
85.92
13.25
99.17
47.03
3Avg SE %
50
39.83
56.28
96.11
84.11
3Avg TIB (min)
50 317.33
302.25
619.58
473.41
3Avg Snooze/TWT (min)
50 101.08
0.42
101.50
18.96
3Avg SOL (min)
50
41.42
0.33
41.75
9.90
PN TST (min)
50 322.50
213.00
535.50
393.98
PN #Wake Bouts
50
79.00
10.00
89.00
43.16
PN WASO (min)
50
91.75
4.25
96.00
45.63
PN SE %
50
26.60
68.23
94.83
84.49
PN TIB (min)
50 368.75
270.00
638.75
466.19
PN Snooze/TWT (min)
50
69.25
0.25
69.50
19.43
PN SOL (min)
50
49.25
0.00
49.25
7.15
MEQ Total Score
50
30.00
31.00
61.00
48.90
KSS Total Score
50
7.00
1.00
8.00
3.66
PSQI Total Score
50
16.00
0.00
16.00
7.12
Baseline Pos PANAS
50
38.00
10.00
48.00
23.44
Baseline Neg PANAS
50
14.00
10.00
24.00
12.94
Avg PTQ Stress
49
2.24
0.61
2.85
1.74
Avg PTQ Performance
49
2.15
0.65
2.80
1.51
Avg PTQ Difficult
49
2.50
2.00
4.50
3.51
Avg PTQ Effort
49
3.00
2.00
5.00
4.11
Avg PTQ Persistent
49
3.00
2.00
5.00
3.70
Avg PTQ Upset
49
3.50
1.00
4.50
3.18
Avg Pos PANAS
49
34.00
13.00
47.00
22.77
Avg Neg PANAS
49
17.50
10.00
27.50
17.02
Avg Baseline HR (bpm)
50
40.68
53.44
94.13
77.39
Avg Task HR (bpm)
50
41.13
54.43
95.56
82.00
Avg Baseline RMSSD (ms) 50 121.89
7.19
129.08
43.74
Avg Task RMSSD (ms)
50
85.45
8.73
94.18
37.05
2
Avg Baseline LF (ms )
50 10376.99 85.79
10462.79
1602.51
2
Avg Task LF (ms )
50 3109.70 143.03
3252.73
1305.51
2
Avg Baseline HF (ms )
50 10824.17 11.25
10835.42
1244.44
2
Avg Task HF (ms )
50 6704.78
22.49
6727.27
851.67
Avg Baseline RESP (Hz)
50
0.16
0.17
0.33
0.24
Avg Task RESP (Hz)
50
0.18
0.20
0.38
0.26
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Std. Deviation
63.12
14.17
21.94
6.76
63.28
18.33
8.10
79.94
16.09
23.18
6.73
87.77
20.14
9.56
7.04
1.56
4.17
8.60
2.85
0.56
0.46
0.70
0.77
0.80
0.84
7.47
4.21
9.33
9.09
24.87
18.97
1660.76
828.94
1752.59
1140.64
0.04
0.04
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Table C.2. Demographic comparison of participants in the SONA sample and lab sample.
Demographic Variable

SONA Sample (N = 360)

Lab Sample (N = 50)

M = 19.70, SD = 2.48

M = 19.54, SD = 1.52

Female

311 (86%)

43 (86%)

Male

46 (13%)

6 (12%)

Transgender

2 (0.6%)

0

Other

1 (0.3%)

1 (2%)

Single

353 (98%)

48 (96%)

Married

5 (1%)

2 (4%)

Widowed

0

0

Separated/Divorced

1 (0.3%)

0

No Response

1 (0.3%)

0

White/Caucasian

304 (84%)

39 (78%)

African American/Black

8 (2%)

3 (6%)

Asian

8 (2%)

1 (2%)

Hispanic/Latino(a)

7 (2%)

1 (2%)

Native American

1 (0.3%)

0

Other

9 (2.5%)

3 (6%)

Multiple races

21 (6%)

3 (6%)

No response

2 (0.6%)

0

Heterosexual

297 (82.5%)

42 (84%)

Lesbian/Gay male

8 (2%)

0

Bisexual

48 (13%)

7 (14%)

Other

6 (2%)

0

No response

1 (0.3%)

1 (2%)

Age
Gender

Marital Status

Ethnicity

Sexual orientation
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Political orientation
Democrat

118 (33%)

19 (38%)

Republican

79 (22%)

5 (1%)

Independent

105 (29%)

13 (26%)

Libertarian

13 (4%)

3 (6%)

Other

17 (5%)

4 (8%)

No response

28 (8%)

6 (12%)

Christian

218 (60.5%)

32 (64%)

Not religious

63 (17.5%)

9 (18%)

Atheist

7 (2%)

1 (2%)

Agnostic

27 (7.5%)

3 (6%)

Jewish

7 (2%)

1 (2%)

Muslim

8 (2%)

2 (4%)

Other

15 (4%)

1 (2%)

Hindu

5 (1%)

0

Buddhist

3 (1%)

0

No response

7 (2%)

1 (2%)

Rural

47 (13%)

5 (1%)

Small town

128 (36%)

17 (34%)

Small city

64 (18%)

12 (24%)

Medium-sized city

37 (10%)

4 (8%)

Suburban

65 (18%)

10 (20%)

Large city

19 (5.3%)

2 (4%)

No response

0

0

Strongly liberal

36 (10%)

5 (1%)

Liberal

77 (21%)

17 (34%)

Religion

Hometown

Political characterization
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Slightly liberal

46 (13%)

5 (1%)

Moderate

103 (29%)

14 (28%)

Slightly conservative

32 (9%)

4 (8%)

Conservative

32 (9%)

1 (2%)

Strongly conservative

12 (3%)

0

No response

22 (6%)

4 (8%)

First

120 (33%)

21 (42%)

Second

120 (33%)

15 (30%)

Third

70 (19%)

6 (12%)

Fourth

23 (6%)

6 (12%)

Fifth or above

14 (4%)

2 (4%)

No response

13 (4%)

0

Healthcare

77 (21%)

5 (1%)

Behavioral & Social Sci.

176 (49%)

21 (42%)

Education

7 (2%)

1 (2%)

Basic Science

49 (14%)

21 (42%)

Other

19 (5%)

1 (2%)

Business

9 (2.5%)

2 (4%)

Arts

8 (2%)

1 (2%)

Agriculture & Natural Sci.

3 (1%)

1 (2%)

Language

1 (0.3%)

0

Engineering

4 (1%)

1 (2%)

Undecided

4 (1%)

1 (2%)

No response

9 (2.5%)

1 (2%)

Year in college

Major *

*Note: Double majors were counted in more than one category
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Table C.3. Correlation Matrix of Sleep, Reactivity, and Potential Covariates
BMI
KSS
MEQ
Pearson
Correlation
3Avg SE
.063
-.110
.116
Sig. (2-tailed)
.662
.448
.423
N
50
50
50
Pearson
Correlation
3Avg TST
-.070
-.054
.199
Sig. (2-tailed)
.627
.707
.167
N
50
50
50
Pearson
Correlation
3Avg SOL
.099
-.064
.026
Sig. (2-tailed)
.494
.658
.859
N
50
50
50
Pearson
Correlation
3Avg TIB
-.125
.010
.180
Sig. (2-tailed)
.386
.943
.212
N
50
50
50
Pearson
Correlation
3Avg WASO
-.008
.009
.082
Sig. (2-tailed)
.956
.952
.573
N
50
50
50
Pearson
Correlation
3Avg #Wake
-.131
.067
.224
Sig.
(2-tailed)
Bouts
.366
.645
.117
N
50
50
50
Pearson
Correlation
3Avg Snooze/
-.064
.266
-.226
Sig.
(2-tailed)
TWT
.658
.062
.114
N
50
50
50
Pearson
Correlation
PN SE
-.112
.104
.088
Sig. (2-tailed)
.439
.473
.544
N
50
50
50
Pearson
Correlation
PN TST
-.213
.022
.172
Sig. (2-tailed)
.137
.879
.232
N
50
50
50
Pearson
Correlation
PN SOL
.040
-.132
.076
Sig. (2-tailed)
.783
.361
.599
N
50
50
50
Pearson
Correlation
PN TIB
-.188
-.012
.156
Sig. (2-tailed)
.190
.934
.279
N
50
50
50
Pearson
Correlation
PN WASO
.025
-.060
.120
Sig. (2-tailed)
.861
.678
.408
N
50
50
50
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PSQI
-.112
.440
50
.006
.969
50
.085
.558
50
.066
.647
50
.223
.119
50
.239
.094
50
.014
.922
50
-.036
.804
50
-.010
.945
50
-.048
.738
50
-.003
.986
50
.187
.193
50
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PN #Wake
Bouts
PN Snooze/
TWT
HR Reactivity

RMSSD
Reactivity
LF Reactivity

HF Reactivity

AUC
(Recovery)
RESP
Reactivity

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N

BMI
-.202
.160
50
-.043
.769
50
-.007
.964
50
.043
.765
50
-.153
.290
50
.128
.377
50
-.043
.768
50
.115
.426
50
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KSS
.023
.876
50
-.010
.943
50
.067
.642
50
.091
.529
50
.013
.928
50
.094
.515
50
-.081
.575
50
.092
.527
50

MEQ
.205
.154
50
-.160
.268
50
.004
.976
50
-.197
.171
50
-.214
.136
50
-.109
.450
50
-.109
.453
50
.182
.205
50

PSQI
.244
.088
50
-.221
.124
50
.208
.147
50
-.044
.760
50
-.080
.581
50
-.013
.931
50
.107
.461
50
-.019
.897
50
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Tables C.4-C.8. Summary Tables for Task Period Reactivity: Task Type (Math, Raven) x Period
(Pre-Task Baseline/Rest, Task) Repeated Measures ANOVAs
3. HR.
SS

df

MS

F

p

ηp2

Task Type

260.15

1

260.15

29.28

< .001

.374

Error (Task Type)

435.36

49

8.89

Task Period

1062.33

1

1062.33

44.24

< .001

.474

Error (Task Period)

1176.72

49

24.02

Type * Period

170.06

1

170.06

19.52

< .001

.285

Error (Type * Period)

426.95

49

8.71

SS

df

MS

F

p

ηp2

Task Type

.016

1

.016

3.37

.072

.064

Error (Task Type)

.235

49

.005

Task Period

.177

1

.177

15.53

< .001

.241

Error (Task Period)

.559

49

.559

Type * Period

.067

1

.067

12.57

< .001

.204

Error (Type * Period)

.260

49

.005

SS

df

MS

F

p

ηp2

Task Type

.590

1

.590

1.89

.176

.037

Error (Task Type)

15.30

49

.312

Task Period

.134

1

.134

.249

.620

.005

Error (Task Period)

26.26

49

.536

Type * Period

.209

1

.209

.695

.408

.014

Error (Type * Period)

14.70

49

.300

Source

4. RMSSD.
Source

5. LF-HRV.
Source
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6. HF-HRV.
SS

df

MS

F

p

ηp2

Task Type

.001

1

.001

.004

.949

.000

Error (Task Type)

10.10

49

.206

Task Period

3.622

1

3.622

11.16

.002

.185

Error (Task Period)

15.91

49

.325

Type * Period

.346

1

.346

1.78

.189

.035

Error (Type * Period)

9.55

49

.195

SS

df

MS

F

p

ηp2

Task Type

.002

1

.002

2.81

.100

.054

Error (Task Type)

.031

49

.001

Task Period

.016

1

.016

11.67

.001

.192

Error (Task Period)

.067

49

.001

Type * Period

.005

1

.005

7.01

.011

.125

Error (Type * Period)

.033

49

.001

Source

7. RESP.
Source

Note: p-values for significant effects are bolded

SLEEP AND CARDIOVASCULAR REACTIVITY
Table C.9. Correlation Matrix of Sleep (Predictor) and Average Task Reactivity (Outcome)Variables
HR
RMSSD
LF
HF
Reactivity Reactivity
Reactivity
Reactivity
3Avg SE
Pearson Correlation
-.256
.100
.036
.071
Sig. (2-tailed)
.073
.489
.805
.625
N
50
50
50
50
3Avg TST
Pearson Correlation
-.105
-.037
-.109
-.042
Sig. (2-tailed)
.467
.796
.453
.771
N
50
50
50
50
3Avg SOL
Pearson Correlation
-.070
.203
.135
.303
Sig. (2-tailed)
.628
.157
.348
.032*
N
50
50
50
50
3Avg TIB
Pearson Correlation
.035
-.100
-.109
-.109
Sig. (2-tailed)
.810
.488
.453
.453
N
50
50
50
50
3Avg WASO
Pearson Correlation
.322
-.332
-.150
-.305
Sig. (2-tailed)
.023*
.018*
.300
.031*
N
50
50
50
50
3Avg #Wake
Pearson Correlation
.201
-.191
.013
-.221
Bouts
Sig. (2-tailed)
.161
.184
.928
.123
N
50
50
50
50
3Avg Snooze/
Pearson Correlation
.015
.201
.068
.161
TWT
Sig. (2-tailed)
.917
.162
.641
.264
N
50
50
50
50
PN SE
Pearson Correlation
-.016
-.080
-.236
-.045
Sig. (2-tailed)
.913
.583
.098
.758
N
50
50
50
50
PN TST
Pearson Correlation
.017
-.077
-.078
-.040
Sig. (2-tailed)
.907
.593
.591
.781
N
50
50
50
50
PN SOL
Pearson Correlation
-.045
.204
.115
.278
Sig. (2-tailed)
.755
.155
.426
.051
N
50
50
50
50
PN TIB
Pearson Correlation
.016
-.055
.015
-.028
Sig. (2-tailed)
.912
.705
.920
.845
N
50
50
50
50
PN WASO
Pearson Correlation
.253
-.301
-.066
-.273
Sig. (2-tailed)
.077
.033*
.647
.056
N
50
50
50
50
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RESP
Reactivity
.025
.864
50
.043
.769
50
-.005
.971
50
.047
.744
50
.025
.864
50
.087
.548
50
-.099
.494
50
.155
.282
50
-.080
.579
50
.026
.856
50
-.136
.348
50
-.051
.726
50

SLEEP AND CARDIOVASCULAR REACTIVITY
HR
RMSSD
Reactivity Reactivity
PN #Wake Bouts Pearson Correlation
.267
-.221
Sig. (2-tailed)
.061
.123
N
50
50
PN Snooze/
Pearson Correlation
-.221
.309
TWT
Sig. (2-tailed)
.123
.029*
N
50
50
Note: * Correlation is significant at the 0.05 level (2-tailed)
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LF
Reactivity
.001
.993
50
.358
.011*
50

HF
Reactivity
-.196
.172
50
.212
.140
50

RESP
Reactivity
.009
.951
50
-.186
.195
50
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APPENDIX D: ANALYSIS OF EXPERIMENTER EFFECTS
Experimenter Gender Sensitivity Analyses
Over the course of the data collection period, 26 participants completed the study
protocol with Experimenter A (female), and 24 participants completed the study protocol with
Experimenter B (male). A series of one-way ANOVAs was conducted to examine whether there
were significant differences between participants who interacted with Experimenter A versus
Experimenter B on measures of average task physiological reactivity, affect, and task appraisals.
Analyses with physiological parameters utilized the average residualized change score for each
parameter.
Reactivity and Recovery
For HF-HRV, there was a significant main effect of Experimenter, F(1, 48) = 4.60, p <
.05, ηp2 = .09, such that HF-HRV reactivity was higher when interacting with Experimenter A (M
= 0.22 log ms2, SD = .81) as compared to Experimenter B (M = -.24 log ms2, SD = .71). No other
physiological reactivity parameters significantly differed between participants who interacted
with Experimenter A versus B (See Summary Tables D.1-D.5). No significant difference was
detected in measures of heart rate recovery (AUC) from the stress tasks between participants that
interacted with Experimenter A and Experimenter B, F(1, 48) = .56, p = .46, ηp2 = .01 (See
Summary Table D.6.).
Positive and Negative Affect
There was no significant main effect of Experimenter on average task positive affect
ratings, F(1, 47) = .56, p = .46, ηp2 = .01, nor for average task ratings of negative affect, F(1, 47)
= .00, p = .97, ηp2 = .00 (See Summary Tables D.7-D.8.).
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Task Appraisals
For feelings of being upset by task performance, there was a significant main effect of
Experimenter, F(1, 47) = 7.94, p < .01, ηp2 = .14, such that participants reported feeling more
upset when interacting with Experimenter A (M = 3.48, SE = .15) as compared to Experimenter
B (M = 2.85, SE = .16). No other task appraisals significantly differed between participants who
interacted with Experimenter A versus B (See Summary Tables D.9-D.14).

Tables D.1-D.6. Summary Tables for Experimenter Effects on Physiological Reactivity and
Recovery: Experimenter (A, B) One-Way ANOVAs
SS

df

MS

F

p

ηp2

HR
Experimenter
Error (Experimenter)

.052
35.84

1
48

.052
.747

.069

.794

.001

RMSSD
Experimenter
Error (Experimenter)

1.49
31.09

1
48

1.49
.648

2.29

.137

.046

HF-HRV
Experimenter
Error (Experimenter)

2.70
28.17

1
48

2.70
.587

4.60

.037*

.087

LF-HRV
Experimenter
Error (Experimenter)

.100
30.71

1
48

.100
.640

.157

.694

.003

RESP
Experimenter
Error (Experimenter)

.410
35.21

1
48

.410
.733

.558

.459

.011

89252.34

1

89252.34

.564

.456

.012

Source

HR (AUC)
Experimenter

Error (Experimenter)
7593039.66
48
1581888.33
Note: * Correlation is significant at the 0.05 level (2-tailed)
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Tables D.7-D.8. Summary Tables for Experimenter Effects on Positive and Negative Affect
Reactivity: Experimenter (A, B) One-Way ANOVAs
SS

df

MS

F

p

ηp2

Positive Affect
Experimenter
Error (Experimenter)

19.81
1676.99

1
47

19.81
35.68

.555

.460

.012

Negative Affect
Experimenter
Error (Experimenter)

.020
33.29

1
47

.020
17.73

.001

.973

.000

Source

Tables D.9-D.14. Summary Tables for Experimenter Effects on Task Appraisals:
Experimenter (A, B) One-Way ANOVAs
SS

df

MS

F

p

ηp2

How Stressful?
Experimenter
Error (Experimenter)

.029
14.89

1
47

.029
.317

.091

.764

.002

How difficult?
Experimenter
Error (Experimenter)

.125
23.62

1
47

.125
.503

.249

.620

.005

How much effort?
Experimenter
Error (Experimenter)

.096
28.04

1
47

.096
.597

.161

.690

.003

How well?
Experimenter
Error (Experimenter)

.115
22.15

1
47

.115
.471

.244

.624

.005

How persistent?
Experimenter
Error (Experimenter)

.003
30.96

1
47

.003
.659

.005

.946

.000

7.94

.007**

.144

Source

How Upset?
Experimenter
4.89
1
4.89
Error (Experimenter)
28.96
47
.616
Note: ** Correlation is significant at the 0.01 level (2-tailed)
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APPENDIX E: ANALYSIS OF TASK ORDER EFFECTS
Another series of one-way ANOVAs was conducted to examine whether there were
significant differences between participants who completed Task Order 1 (math task followed by
Raven’s task) and Task Order 2 (Raven’s task followed by math task) on measures of average
task physiological reactivity, affect, and task appraisals. Analyses with physiological parameters
utilized the average residualized change score for each parameter.
Reactivity and Recovery
There was no significant main effect of Task Order for measures of physiological
reactivity, nor heart rate recovery, F(1, 48) = 1.93, p = .17, ηp2 = .04. (See summary Tables E.1E.6).
Positive and Negative Affect
There was no significant main effect of Task Order for measures of average task positive
affect ratings, F(1, 47) = .06, p = .81, ηp2 = .00, nor for measures of average task ratings of
negative affect, F(1, 47) = 0.10, p = .76, ηp2 = .00 (See Summary Tables E.7-E.8.).
Task Appraisals
For ratings of feelings of stress elicited by the tasks, there was a significant main effect of
Task Order, F(1, 47) = 6.31, p < .05, ηp2 = .12, such that participants reported feeling more
stressed when they completed Task Order 2 (M = 3.80, SE = .17) as compared to Task Order 1
(M = 3.21, SE = .16). A mixed-factors ANOVA was conducted to determine how each task type
may have influenced this finding. Results revealed no significant main effect of Task Type and
no significant interaction between Task Type and Task Order. No other task appraisals
significantly differed between participants who completed the experimental session using Task
Order 1 or Task Order 2 (See Summary Tables E.9-E.14.).
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Tables E.1-E6. Summary Tables for Task Order Effects on Physiological Reactivity and
Recovery: Task Order (1, 2) One-Way ANOVAs
Source
SS
df
MS
F
p
ηp2
HR
Task Order
Error (Task Order)

.181
35.71

1
48

.1881
.744

.244

.624

.005

RMSSD
Task Order
Error (Task Order)

1.25
31.32

1
48

1.25
.653

1.91

.173

.038

HF-HRV
Task Order
Error (Task Order)

1.24
29.63

1
48

1.24
.617

2.01

.163

.040

LF-HRV
Task Order
Error (Task Order)

.893
29.92

1
48

.893
.623

1.43

.237

.029

RESP
Task Order
Error (Task Order)

.391
35.23

1
48

.391
.734

.533

.469

.011

HR (AUC)
Task Order
Error (Task Order)

297048.49
7385243.51

1
48

297048.49
153859.24

1.93

.171

.039
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Tables E.7-E.8. Summary Tables for Task Order Effects on Positive and Negative Affect
Reactivity: Task Order (1, 2) One-Way ANOVAs
SS

df

MS

F

p

ηp2

Positive Affect
Task Order
Error (Task Order)

2.02
1694.78

1
47

2.02
36.06

.056

.814

.001

Negative Affect
Task Order
Error (Task Order)

1.72
831.59

1
47

1.72
17.69

.097

.757

.002

Source

Tables E.9-E.14. Summary Tables for Task Order Effects on Task Appraisals: Task Order (1,
2) One-Way ANOVAs
Source
SS
df
MS
F
p
ηp2
How Stressful?
Task Order
Error (Task Order)

1.73
13.19

1
47

1.73
.281

6.31

.017*

.116

How difficult?
Task Order
Error (Task Order)

.048
23.70

1
47

.048
.504

.095

.759

.002

How much effort?
Task Order
Error (Task Order)

.479
27.65

1
47

.479
.588

.814

.371

.017

How well?
Task Order
Error (Task Order)

1.11
21.15

1
47

1.11
.450

2.47

.123

.050

How persistent?
Task Order
Error (Task Order)

1.19
29.77

1
47

1.19
.633

1.87

.178

.038

.597

.444

.013

How Upset?
Task Order
.424
1
.424
Error (Task Order)
33.42
47
.711
Note: * Correlation is significant at the 0.05 level (2-tailed)

